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GENERAL INTRODUCTION 
The ability of gut bacteria to structurally modify steroids has 
important ramifications. Slight structural changes can dramatically 
affect function or biological activity. Previous research on bacterial 
steroid biotransformations has primarily dealt with the three major 
classes of steroids which pass through the gastrointestinal tract: 
cholesterol, steroid hormones, and bile acids. Recently, vitamin D3 (a 
9,10 seco-steroid) has been shown to undergo bacterial-catalyzed 
C-10(19) oxidation, yielding the major product 5(E)-19-nor-10-keto-
vitamin D3 (lO-keto-Da). This compound has also been detected in the 
plasma of cows receiving large oral doses of vitamin D3, thus denoting 
in vivo production. 
Biological assays with lO-keto-Dg revealed that the C-10(19) 
oxidative pathway represents a deactivation process in vitamin D me­
tabolism. Whether or not the vitamin D status of an animal is affected 
by the bacterial removal of vitamin D has yet to be determined. 
The production of lO-keto-Ds could also be an important process in 
monogastric animals since vitamin D3, 25-hydroxyvitamin D3, and 1,25-
dihydroxyvitamin D3 circulated in the enterohepatic cycle. In addition 
to this cycle, diet represents the other major route by which vitamin D 
enters the gut. Results obtained from ruminai systems should also 
transfer to monogastric animals since the rumen is a model of study for 
the microbiology of the cecum and large intestine. In light of current 
trends of providing large oral doses of vitamin D for domestic animals 
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in feeds, or administered clinically, a great deal of substrate may be 
available for the metabolism of vitamin D by gut bacteria. 
Therefore, the first phase of this study involves defining the 
conditions necessary for bacterial C-10(19) oxidative metabolism to 
occur. It is hoped that this work will help to clarify the situation 
in vivo. The second part reports the isolation, purification, and bio­
logical assessment of lO-keto-Dg and "Peak A," a new bacterial metabo­
lite of vitamin Dg. 
Dissertation Format 
This dissertation is presented in the alternate thesis format, and 
includes two manuscripts to be submitted for publication in (1) Applied 
and Environmental Microbiology, and in (2) Biochemical and Biophysical 
Research Communications. The format used in this dissertation is that 
of the American Society for Microbiology. An in-depth literature re­
view precedes the first manuscript. At the end of each section, a sep­
arate literature cited section has been included to facilitate publica­
tion. A general summary and discussion follow the final manuscript. 
The doctoral candidate, Robert Marshall Gardner, was the principal 
investigator in each of these studies, with the exception of the 
pharmacokinetics and binding assays which were performed by R. L. 
Horst. 
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LITERATURE REVIEW 
This literature review is divided into two major sections. Part I 
will deal with bacterial biotransformation of steroids in the gastro­
intestinal tract; Part II contains a summary of selected literature on 
the vitamin D-endocrine system. 
Bacterial Transformations of Steroids in the 
Gastrointestinal (GI) Tract 
Importance and implications 
Anaerobic bacteria in the GI tract play an important role in al­
tering the structure of many endogenous and dietary steroids (38, 41, 
89). Certain structural modifications of the parent steroid can impart 
unique biological activity, or inhibit inherent activity, resulting in 
important physiological changes in the host. Both situations should be 
considered when steroids are administered orally (2, 14, 28) or if they 
undergo enterohepatic circulation (8). These biologically altered com­
pounds, in many instances, can be reabsorbed back into the body, either 
directly through the cell membranes of the intestinal epithelium or by 
the enterohepatic cycle (30, 38, 89). After absorption, further modi­
fication of the steroid may occur in the liver (89) . Research with 
steroid biotransformations by intestinal bacteria has emphasized the 
three major classes of steroids which pass through the GI tract; these 
are the bile acids (43, 78, 92, 94, 103), cholesterol (18, 39, 143, 
147), and steroid hormones (14, 16, 154). Although this review will 
almost exclusively deal with bacteria, it should be noted that protozoa 
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and fungi can also play an important role in steroid biotransformations 
(21, 60, 121). 
Several epidemiology studies provide evidence for a strong corre­
lation between the levels (in the colon) of certain bacterial metabo­
lites of bile and cholesterol and the incidence of colon cancer (58, 
59, 102, 108, 116). These transformation products are thought to act 
as carcinogens or cocarcinogens. The bacteria responsible for produc­
tion of these suspect compounds increase markedly on diets high in fat 
content (under these conditions bile production likewise increases), 
which have been frequently linked with the etiology of colon cancer 
(68, 108). A high-risk diet can alter the metabolic activity of the 
gut microflora and this in turn could play a role in the etiology of 
cancer of the large bowel (116). The hypothesis supporting bacterial 
involvement in the etiology of colon cancer is still controversial (37, 
108). Unfortunately, for rapid progress in this area, dietary factors 
are so interwoven with bacterial involvement that interactions between 
the two result in a complex situation which tends to obscure individual 
contributions. 
Bacterial steroid transformations may also exert subtle influences 
on host physiology. The modification of bile acids by bacteria can 
influence, for example, the absorption of other neutral steroids and 
fatty acids. The intestinal flora influences the types of bile acids 
produced, their turnover time, and excretion rate, thereby affecting 
the absorption of other lipophilic material (38). In addition to bac­
teria, the types of bile acids along the GI tract are also influenced 
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by other factors such as diet, enterohepatic circulation, and intesti­
nal motility (19)• Fecal bile acid composition might change markedly 
with changes in the intestinal flora (30). This is supported by the 
observation that the small intestines of gnotobiotic rats contain at 
least twice the amount of bile acids found in conventional rats. 
Lithocholic (3a—hydroxy-56-cholan-24-oic) acid, a product of microbial 
bile metabolism, is a toxic compound and provokes cholangiofibrosis. 
In rats given a protein-deficient diet, lithocholic acid induced ductu-
lar cell proliferation and formation of gall stones (38). Gastroin­
testinal bacteria influence plasma cholesterol levels by metabolizing 
cholesterol in the gut (109). Therefore, it is logical that these bac­
teria may also be a contributing factor in atherosclerosis. These ex­
amples illustrate the extent with which the flora can interact with its 
host. 
Bacteria also influence the fate of steroids by methods other than 
direct metabolism. Mott et al. (109) believe that factors such as bulk 
of feces, intestinal transit time, and the binding of steroids (all 
three of which are affected by intestinal bacteria) are important. 
Steroid-transforming bacteria are not unique to any particular 
genus, habitat, or mode of metabolism. They represent a very diverse 
group of organisms, as might be expected from the diversity of steroid-
transforming reactions documented. These are classified into six major 
reactions categories: (1) oxidation; (2) reduction; (3) esterification, 
amide formation, and hydrolysis; (4) isomerization; (5) miscellaneous 
addition, rearrangement, and elimination processes; and (6) resolution 
6 
of d-1 mixtures (21). In many instances, the bacterial transformation 
of a steroid (even in pure culture) is not limited to any one reaction 
type. Biotransformations of steroids by bacterial enzymes are, how­
ever, stereo-specific, and usually represent a very small change in 
structure — hence, the term "transformation" is more appropriate than 
the term "degradation." Industries which produce biologically active 
steroid drugs for clinical use commonly take advantage of a particular 
microbial transformation to synthesize a desired steroid from rela­
tively common and easily attained starting material (i.e., cholesterol 
or bile) (3, 84). Given the wide diversity of reaction types, the pro­
duction of very complex steroids can be greatly aided by bacteria. 
Microbiological methods are often easier and less expensive than organ­
ic chemical syntheses. 
Bile 
Perhaps the most important steroid transformations that take place 
in the GI tract involve the bile acids (64, 105). Most bile acids are 
derived from cholesterol and qualitatively represent the most important 
end products of cholesterol metabolism (38) . Conventional animals 
(those with a normal flora) can compensate for the increased loss of 
bile acids due to bacteria by increasing the rate of oxidative catabo-
lism of cholesterol. 
Bile acids are classified as either primary or secondary deriva­
tives, depending upon their origin. Primary bile acids are produced in 
the liver and are unaltered by intestinal bacterial enzymes. Usually, 
the primary bile acids are differentiated from secondary or microbial 
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metabolites by the use of germ-free animals. In germ-free rats vs. 
conventional, the major fecal bile acids are 6-muricholic (3a,66,76-
trihydroxy-56-cholan-24-oic) acid and cholic (3a,7a,12a-trihydroxy-
5B-cholan-24—oic) acid. Chenodeoxycholic (3a,7a-dihydroxy-56-cholan-
24-oic) acid and a-muricholic (3a,66,7a-trihydroxy-56-cholan-24-oic) 
acid are also present in minor amounts (118). In humans, the major 
primary bile acids are cholic and chenodeoxycholic acids. Human gall­
bladder bile contains about 70% primary bile acids, 25% 7-dehydroxy-
lated bile acids (mostly deoxycholic acid and to a lesser extent 
lithocholic acid), and 5% urso-bile acids [almost all ursodeoxycholate 
(3a,73-dihydroxy-53-cholan-24-oic)]. 
Bacterial metabolism of intestinal steroids may be closely tied to 
the enterohepatic cycle, which allows many endogenous steroids to gain 
entrance into the gut. The utilization of these steroids as a sub­
strate for biotransformation reactions may affect the circulating lev­
els of various steroids. 
Most of the steroids in the enterohepatic cycle are conjugated to 
some compound which renders them more polar and water-soluble. The 
secondary bile acids, as well as the primary bile acids, are conjugated 
with either glycine or taurine during hepatic passage (89). When iso­
lated from feces, however, they are found as free acids due to the ex­
tensive microbial hydrolysis (7), which is considered the major initial 
reaction in the microbial transformation of bile salts (6). Species of 
secondary bile acids predominate in feces, of which deoxycholic 
(3a,12a-dihydroxy-56-cholan-24-oic) acid accounts for over 50%. 
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Conjugation of a neutral steroid is determined by its chemical struc­
ture. For example, and steroids with 3cx-hydroxy-56-struc-
tures are usually conjugated with glucuronic acid, while 3a-hydroxy-5a 
and 36-hydroxy-5a steroids generally form sulfates (89). 
Numerous intestinal bacteria deconjugate taurine or glycine conju­
gates (63, 92). "Clostridia," which deconjugate both bile salts, in­
clude C^. perfringens, _C. bifermentans, and C^. sordelli. Clostridium 
septicum, however, could only hydrolyze the glycine conjugate (63). 
Aries and Hill (7) found that the cholanylglycine hydrolase in several 
fecal bacteria, including Bacteroides sp., Bifidobacterium sp., 
Clostridium sp., and Streptococcus sp., all had pH optima below 6.0. 
The enzyme also required highly anaerobic conditions or the presence of 
a reducing agent. 
The mouse liver sulfoconjugation of cholic acid occurs predomi­
nantly at the 7a-hydroxyl group, and cholic acid 7-sulfate accounts for 
more than 40% of the total bile acids in mice. Humans and rats sulfo-
conjugate bile acids predominantly at the 3-hydroxyl group. Man and 
the rat contain only trace amounts of sulfated bile acids (74) due to 
microbial deconjugation. Through desulfation, bile sulfates are con­
verted into less polar and thus more efficiently absorbed substrates. 
Huijghebaert et al. (74) demonstrated that the microbial bile salt 
sulfatase in fecal cultures of man, rat, and mouse is limited to the 
hydrolysis of the 3-sulfate esters of bile acids. Sulfation at the C-7 
or C-12 hydroxy1 group decreases or completely prevents further mi­
crobial transformation in the gut. 
9 
Several steroids can also be conjugated to glucuronides. Cortico­
steroids and vitamin D are two examples (8, 48, 89). The ability of 
fecal microbes to hydrolyze glucuronide conjugates is higher in Ameri­
cans than in populations at lower risk of developing colon cancer (102). 
These findings suggest that dietary composition is a major factor in 
determining the bacterial ^-glucuronidase activity. 
When the primary bile acids enter the GI tract, bacteria transform 
them into a large number of secondary metabolites. The major reactions 
inc3.ude the hydrolysis of bile salt conjugates, dehydroxylation of the 
hydroxy1 group at C-7, and dehydrogenases that oxidize the hydroxy1 
groups at carbons 3, 7, or 12, as well as reducing the 3-keto group to 
both a- and S-hydroxyls (78). Secondary bile acids can be further 
metabolized by the liver, which complicates their classification as to 
origin (38). 
The most important bile acid transformations, from a physiological 
perspective, are the conversion of cholic and chenodeoxycholic acids 
into deoxycholic and lithocholic acids, respectively, by 7a-dehydroxy-
lation (64, 105). This reaction is thought to occur in or on the 
cytoplasmic membrane of the bacterial cell (133). In humans, 7a-dehy-
droxylating bacteria do not become established in the gut before the 
ages of 12-18 months (38). 
A two-step biochemical mechanism for 7a-dehydroxylation was pro­
posed by Samuelsson in 1960 (120). The first step involves the elimi­
nation of the 6g-hydrogen and the 7a-hydroxyl group. This results in a 
structure, which is rapidly transhydrogenated at the 6a- and 78-
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positions. The complete dehydroxylation reaction may involve the same 
enzyme or an enzyme complex (148). Hydrogénation probably benefits 
from a low redox potential where electron donors predominate; this fact 
can account for the additional emphasis placed on the need for strict 
anaerobic conditions (6). If the hydrogénation step is rapid and not a 
rate-limiting step, the apparent need for strict anaerobiosis is less 
obvious (4). This is supported by Masuda and Oda (103), who explored 
the dehydroxylation process under different atmospheric conditions with 
washed cells of a Clostridium-like organism. When oxygen was allowed 
to enter the system by diffusion, cholic acid was 7a-dehydroxylated to 
deoxycholic acid. The resulting deoxycholate was further 12a-dehydro-
genated under aerobic conditions to 12-keto-lithocholate and the 3,12-
diketo derivative of deoxycholic acid. However, when the reaction mix­
ture was aerobically incubated on a shaker, the dehydroxylation process 
was completely eliminated, and only oxidative dehydrogenation took 
place. Under these conditions, cholate was converted to 7-keto-cholate, 
which was further oxidized to 7,12—diketo-cholate. The dehydroxylase 
enzyme in Eubacterium lentum also is active under aerobic conditions 
(105). Archer et al. (4) investigated specific inhibitors of 7a-dehy-
drogenation which would have no effect on dehydroxylation. Both 7a-de-
hydrogenation and 7a-dehydroxylation were dramatically increased when 
washed cells of Clostridium bifermentans were incubated in the presence 
of molecular oxygen as compared with yields under oxygen-free condi­
tions (4). The stimulatory effect of oxygen on dehydrogenation agrees 
with the observations of Aries and Hill (6) that oxygen is necessary 
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for dehydrogenation of cholxc acid by cell-free extracts of several 
anaerobes. There have also been other reports of aerobic 7a-dehydroxy-
lation. Hayakawa and Samuelsson (54) discovered 7-deoxy-bile acids 
among the degradation products when Corynebacterium simplex (not a mem­
ber of normal flora) was grown aerobically with sodium cholate as the 
sole carbon source. The mechanism for the reaction is probably differ­
ent from that employed by intestinal bacteria. 
Several investigators have isolated bacteria from the intestine, 
cecum, and feces that can catalyze the 7a-dehydroxylation of cholic and 
chenodeoxycholic acids (6, 51, 64, 103, 105). Aries and Hill (6) iso­
lated this activity from Escherichia coli, Bacteroides sp., Clostridium 
welchii, and Streptococcus feacalis. Masuda et al. (104) noted that 
with resting cells of Eubacterium lentum a progressive enhancement of 
the 7a-dehydroxylase activity was caused by increasing the amount of 
flavin mononucleotide (FMN). Almost complete dehydroxylation of che­
late and chenodeoxycholate occurred when the concentration of FMN was 
equivalent to that of the substrate bile acids. Reduced flavins are 
thought to be required as electron donors in the reductive process of 
7a-dehydroxylation. Hirano et al. (64) examined 13 bacteria from feces 
which could dehydroxylate 7-hydroxy-bile acids. Most of the fecal bac­
teria that could dehydroxylate bile acids could also catalyze 7a-dehy-
drogenation, giving rise to the formation of 7-keto derivatives. This 
process, unlike that of dehydroxylation, was reversible. Archer et al. 
(3) noted that Clostridium blfermentans (a bacterium capable of 7a-dehy-
droxylation) also produced 7-keto-deoxycholic acid. Cell growth and 
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7-keto-deoxycholate production were largely complete by 12 hours, 
whereas dehydroxylation was strongest at about 18 hours of incubation. 
Hirano et al. (64) contended that 7a-dehydroxylation took place early 
in incubation and ceased after 24 hours. 
It has generally been observed that 7a-dehydroxylase is produced 
only in a medium containing 7a-hydroxy bile acids (103). The relative 
activity of dehydroxylating organisms differed with substrates; cheno-
deoxycholate acid induced higher rates of 7a-dehydroxylation than did 
cholate (64). Many of the bacteria isolated from feces that were posi­
tive for 7a-dehydroxylation were also capable of deconjugating glycine 
and taurine conjugates. 
Optimal 7a-dehydroxylation by fecal bacteria (from man) was ob­
served when the pH was 7.0, and was markedly inhibited at the low pH 
obtained when fermentation was stimulated in man by adding lactulose to 
the diet (27). Under these conditions, the proportion of deoxycholic 
acid in the bile also decreases significantly. Masuda and Oda (103) 
noted that when excessive glucose was added to the growth medium, it 
appreciably reduced the levels of 7a-dehydroxylase. This may be a pH 
effect because he reported pH optima of 6.5 to 7.0. 
White et al. (148) described the regulation by pyridine nucleo­
tides of a 7a-dehydroxylase in Eubacterium sp. V.P.I. 12708. The pro­
duction of maximal 7-dehydroxylase activity required the addition of 
NAD when extracts prepared from cholic acid-induced cells had been 
dialyzed under anaerobic conditions. NAD"*" is also required for the 
reduction of the intermediate proposed by Samuelsson (120). 
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Reduction of the intermediate (3a-hydroxy-56-6-cholan-24-oic) to 
lithocholic acid significantly increased with the addition of NAD^, and 
also FADH^ and (added to mixtures containing NAD^) (148) . NADH 
appeared to be inhibitory. White et al. (148) concluded that the 
NAD^/NADH ratio may be important in the regulation of 7-dehydroxylase 
activity within the cell. The exact role of NAD"^ remains unclear, 
since no net reduction or metabolism of NAD"*" associated with 7-dehy-
droxylation was observed. NAD"*" may be acting as an activator. The 
data also indicated that 7-dehydroxylase required a free C-24 carboxyl 
group because conjugates were not active substrates. An uninhibited 
7a- or 76-hydroxyl group on the S-ring of the steroid nucleus was also 
essential. 
Lipsky and Hylemon (87) reported that cholic acid induced 7a-dehy-
droxylase and NADH:flavin oxidoreductase activities in cell extracts of 
Eubacterium sp. The oxidoreductase had an absolute specificity for 
NADH; this differs from the results of White et al. (148). A relative 
molecular weight of 260,000 was determined; this is much higher than 
similar enzymes reported from other workers. The exact physiological 
relationship of NADH:flavin oxidoreductase and 7a-dehydroxylase in this 
bacterium is not clear. However, 7a-dehydroxylation activity in an— 
aerobically dialyzed cell extracts of this organism were highly stimu­
lated by reduced flavins. Furthermore, 7a-dehydroxylase activity and 
oxidoreductase are both rapidly induced by sodium cholate. Hence, 
NADH:flavin oxidoreductase may supply reduced free flavins for 7a-dehy-
droxylase activity (87). Masuda et al. (105) observed that the 
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addition of flavin mononucleotide (FMN) to the growth medium signifi­
cantly increased the 7a-dehydroxylation of bile without an increase in 
cell growth. The addition of FMN to the growth medium did not affect 
the production of 7a-dehydroxylase. When FMN was included in a reac­
tion mixture of resting cells, enzyme activity was inhibited. 
Some bacteria capable of 7a-dehydroxylating chenodeoxycholic acid 
were also able to oxidize the hydroxy1 groups at positions C-3 and C-7 
to keto functions (3, 51, 105). Gustafsson et al. (51) isolated the 
following metabolites from pure cultures of fecal bacteria incubated 
with chenodeoxycholate: 3-keto-7a-hydroxy-56-cholanoic acid, 3ct-
hydroxy-56-cholanoic acid, and 3-keto-5S-cholanoic acid. Taxo-
nomically, these active bacteria appeared to be members of the genus 
Clostridium. However, these strains were unable to deconjugate bile 
acids. In mixed cultures of fecal bacteria, extensive reduction of the 
3-keto group to 36-hydroxy occurred. No organism was isolated for this 
reductive activity, however. 
Due to the potential harm that arises from 7-dehydroxylation, nu­
merous efforts to inhibit this reaction i^ vivo have been attempted 
(91, 94, 95, 98). Epimerization (involves a hydroxysteroid dehydro­
genase, and involves the conversion of an a-hydroxyl group to the B-po-
sition) is a reaction which competes with 7a-dehydroxylation and can 
benefit the host (95). Epimerization appears to go through a 7-keto 
intermediate, whereas dehydroxylation by Eubacterium sp. and other 
fecal bacteria appears to go through ^ unsaturated intermediates. 
The major product of hydroxysteroid dehydrogenase is ursodeoxycholate 
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(the fourth most prevalent bile acid in human bile), the 7g-hydroxy 
epimer of chenodeoxycholic acid (62). This acid is in current use as 
an efficient cholesterol gallstone-dissolving agent. 
Ursodeoxycholic acid is formed vivo from chenodeoxycholic acid, 
largely via the intermediate 7-keto-lithocholic acid by a microbial 
7a-hydroxysteroid dehydrogenase. The product of this reaction is sub­
sequently reduced by 7 6-hydroxysteroid dehydrogenase to yield ursode­
oxycholic acid which is very resistant to 7a-dehydroxy3ation (96). A 
7a-hydroxycholanyl dehydrogenase has been observed in Clostridium 
welchii, Escherichia coli, and Bacteroides sp. The enzyme from C^ . 
welchii was NADP^-dependent, while that of coli and Bacteroides sp. 
were NAD^-dependent. Generally, the hydroxycholanyl dehydrogenase 
produced by gram-negative bacteria are NAD^-dependent, while these 
enzymes from gram-positive bacteria are NADP^-dependent, and enzymes 
from both gram-positive and gram-negative required oxygen (6). Conju­
gated bile acids are poor substrates for hydroxycholanyl dehydrogenase 
and 7-dehydroxylase enzymes; this supports the contention that the 
major initial reaction in the catabolism of bile salts by intestinal 
bacteria is hydrolysis of the amide bond to release free bile acids 
( 6 ) .  
Macdonald et al. (98) developed a method to rapidly quantitate 
76-hydroxyl groups in bile samples (from humans and bears) by using 
purified 76-hydroxysteroid dehydrogenase from a preparation of 
Clostridium absonum (98). Clostridium absonum formed ursocholate (from 
cholate), and ursodeoxycholate (from chenodeoxycholate), but could not 
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transform deoxycholate in whole-cell cultures (91, 95). This organism 
is considered to be a "low population" intestinal anaerobe, and is 
taxonomically very similar to C^. perfringens and C^. paraperf ring ens, 
neither of which can transform bile acids. 
Epimerases appear to be dependent on either NAD or NADP^ (93). 
Two different types of hydroxysteroid dehydrogenase have been docu­
mented. The form specific for a 7a-hydroxyl group uses chenodeoxy-
cholic acid as a substrate. The other requires a 76-hydroxyl group and 
uses ursodeoxycholate as a substrate. Optimal pH for the 7c(-enzyme 
ranged from 9.5 to 11, the 76-enzyme's optimal range was from 9 to 10. 
These may represent two entirely different enzjTnes (93). It was ob­
served that when C_. absonum was added to cultures of Eubacterium sp. 
(active in 7a-dehydroxylating bile), 7a-dehydroxylation of chenodeoxy-
cholate to lithocholate was totally prevented (90) . Deoxycholate for­
mation was reduced by 50% when the substrate was cholate. In the pres­
ence of C^. absonum, as expected, the formation of 76-hydroxy and 
7-keto-bile acids took precedence over the formation of 7a-dehydroxy-
lated bile acids. When C^. absonum was added to mixed cultures of fecal 
bacteria, lithocholic acid production did not decrease, but the forma­
tion of ursodeoxycholic acid was produced at the expense of 7—keto 
acids. The 7a- and 76-epimerases in C^. absonum are induced by primary 
bile salts or deoxycholate and repressed by the end product, ursodeoxy­
cholate (95). Macdonald et al. (97) have partially purified these two 
enzymes. 
Hylemon and Sherrod (77) demonstrated that multiple forms of the 
enzyme 7a-hydroxysteroid dehydrogenase were present in Bacteroides 
fragilis. The enzymes differed with respect to their pyridine nucleo­
tide specificity, thermal stability, divalent metal cation require­
ments, and elution profiles from Sephadex G-200 columns. The NAD"*"-
dependent enzyme had a molecular weight of approximately 80,000, and 
the NADP^-dependent enzyme 120,000. It was also noted that the 
7a-hydroxy group was oxidized only after glucose was nearly depleted 
from the growth medium. Sherrod and Hylemon (124) purified a NAD"""— 
dependent 7c(—hydroxysteroid dehydrogenase from Bacteroides 
thetaiomicron which oxidized cholate to 7-keto-deoxycholate. This 
ability increased when cells were incubated in the presence of poten­
tial electron acceptors such as fumarate, menadione, or molecular oxy­
gen. This suggests that bile acids may serve as potential energy 
sources in the absence of fermentable carbohydrates (77, 124). 
Eubacterium aerofaciens and Peptostreptococcus productus have only 
a 76-hydroxysteroid dehydrogenase that specifically oxidizes the 
76-hydroxyl group in the cholane nucleus to a 7-keto group; NADP"*" is an 
electron acceptor. This enzyme activity was inhibited when excessive 
amounts of fermentable substrate were added to the medium. It was also 
observed that sulfhydryl inhibitors, such as p-chloromercuribenzoate 
and iodoacetate, greatly repressed the enzymic activity, suggesting the 
involvement of active sulfhydryl groups in dehydrogenation (62). 
Clostridial species have both a 7a- and 76-enzymes, and can perform 
epimerization by themselves (62). Peptostreptococcus productus 
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and aerofaciens are certainly major species of the intestinal micro­
flora as opposed to the clostridial species, which are rare in the GI 
tract. Peptostreptococcus productus and aerofaciens affected only 
bile acids or bile salts which have a 7g-hydroxy group with the reduc­
tion to NADP"*" (not NAD^) and the formation of a 7-keto derivative as 
the sole product. 
Oral administration of chenodeoxycholic-oxazoline in low amounts 
effectively blocks 7-dehydroxylation in rats. Macdonald et al. (96) 
studied the effect of bile acid oxazolines on 7-epimerization. The 
bile acid oxazolines appear to interfere with the epimerization of pri­
mary bile acids at the 7-position by inhibiting the growth of the or­
ganisms that participate in the reaction (with the notable exception of 
_E. coli) . 
Hylemon and Stellwag (78) studied the conversion of cholate to 
7-keto-deoxycholate and found that the peptidcglycan layer of the cell 
wall acts as a significant permeability barrier to cholate; greater 
rates of transformation in lysozyme-treated cells were obtained. Gram-
negative bacteria may play a more important role in cholate transforma­
tion in the gut than do the gram-positive bacteria. Hylemon and 
Stellwag (78) suggest that the transformation reaction occurs in or on 
the cytoplasmic membrane. 
Eubacterium lentum 7a-dehydrogenates cholic and chenodeoxycholic 
acids to their respective 7-keto acids, while concurrently catalyzing 
the conversion of the 3a-hydroxyl group to 3—keto and 36-hydroxy deriv­
atives (61). An interesting relationship between products obtained and 
19 
the incubating atmosphere was observed. When compared, anaerobically 
growing and resting cells possessed essentially the same metabolism. 
However, aeration of resting cells completely inhibited the dehydro-
genation of the 7a-hydroxyl group of cholic and chenodeoxycholic acid, 
whereas dehydrogenation at positions C-3 or C-12, or both, were signifi­
cantly enhanced. Under anaerobic conditions, cholic and chenodeoxy­
cholic acids were 7a-dehydrogenated, yielding a large quantity of 7-
keto-lithocholic acid. The 3—position was epimerized as well as oxi­
dized under aerobic conditions. There seems to exist the following 
incompatibility between the dehydrogenation at C-7 and at C-12 in 
cholic acid: extensive 7a-dehydrogenation under anaerobic incubation 
and only 12a—dehydrogenation in an aerated system. Eubacterium lentum 
seems to elaborate the whole series of Sa-, 7a-, and 12a-dehydrogenases, 
and the 3a—dehydrogenase activity of this organism is closely associ­
ated with the epimerization of the concerned hydroxyl group (61), As a 
rule, dehydrogenating keto formation is stimulated by aeration, presum­
ably because of the use of oxygen as an effective terminal electron 
acceptor, or by raising the Eh, but this organism appears to be an ex­
ception (61). The epimerizing conversion of the 3a-hydroxyl group by 
lentum, which presumably involves a reductive process from a 3-keto 
to a 36-hydroxyl group, was suppressed by aerobic conditions. Beher et 
al. (9) have developed a rapid photometric method to determine free and 
esterified 3a-hydroxy fecal bile acids (9). 
Another important transformation is the epimerization of the 
3a-hydroxy group to a 3g-position. This reaction involves those bile 
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acids with 3ct-hydroxyl groups; cholate, chenodeoxycholate and deoxy-
cholate= The reaction mechanism presumably precedes through a 3-keto 
intermediate (63, 92). Macdonald et al. (92) demonstrated that with C^ . 
perfringens the 3-keto compound accumulated late in the growth curve 
when Eh values were above -120 mV. These findings were consistent with 
those of Hirano et al. (63), who showed that the 3—keto derivative 
could be obtained with aerated washed cells (of C^. perfringens) , but 
not with whole cells maintained under anaerobic conditions. A broad pH 
optimum between 7.0 and 9.0 was noted for 3a-epimerization. The activ­
ity was significantly reduced at pH 6.0 and barely detectable at pH 
5.0. These data strongly suggested that ketone production was inhib­
ited in media containing a fermentable substrate. Oxygen may serve as 
a terminal electron acceptor for the dehydrogenation reaction, or it 
may be involved in elevating the Eh or redox potential of the medium. 
Macdonald et al. (92) offered an alternate explanation for the role of 
oxygen which involves the NADP'^/NADPH ratios in the cell. This ratio 
increased as the Eh of the medium increased. Interestingly, although 
the 3—keto compound was formed by different strains of C^. perfringens, 
not all of these strains produced the 36-epimers, suggesting the need 
for two distinct enzymes. 
3B,12a-dihydroxy—58-cholanic acid has been recently isolated from 
rabbit feces and identified (29, 30). It was found to be a metabolite 
of deoxycholic acid, and could not be found in the bile nor could it be 
reabsorbed due to this transformation (30, 102). 
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There have been several reports of lithocholic acid metabolism by 
bacteria, but few which involve extensive degradation of the side-chain 
(114). Owen and Bilton (114) demonstrated that Pseudomonas sp. strain 
NCIB 10590 could metabolize the side-chains of these steroids. Metabo­
lism differed markedly with the type of incubating atmosphere used. 
Under aerobic conditions, neutral metabolites were the major products, 
whereas under anaerobic conditions significant accumulation of acidic 
metabolites were observed. Leppik et al. (84) reported that optimal 
bile acid metabolism by a Pseudomonas sp. occurred when low aeration 
rates were used (84) . The major metabolites detected were 3,17-keto-4 
ene or 17,3-keto-l,4 diene compounds. This pseudomonad grows in the 
presence of 4% bile and has potential as an agent for industrial bio-
conversion. Hayakawa et al. (53) suggested that the introduction of 
4 A -3—keto structure for the microbial breakdown of bile an indispens­
able process for the shortening of the side-chain of cholic acid by 
Streptomyces gelaticus. 
Humans are unable to transform 6-muricholic acid (118), but rats 
and mice transform it into w-muricholic (3a,6a,76—trihydroxy-53-cholan-
24-oic) acid (40). Sacquet et al. (118) explored whether bacteria from 
the human digestive tracts were capable of initiating the transforma­
tion of B-muricholic acid (which does not exist in rats) in gnotobiotic 
rats by inoculating them with human feces. Their results support the 
finding that 6-muricholic acid-transforming bacteria are absent in the 
human microflora. However, 6-muricholic acid-transforming bacteria 
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must have been present in the human donors, but they did not thrive in 
the rat. 
Secondary bile acids derived from S-muricholic acid include 
(D-muricholic and hyodeoxycholic (3a,6a-dehydroxy-56-cholanoic acid) 
acid. Eyssen et al. (40) studied this conversion and found that it 
proceeded in a two-step process. The first reaction was catalyzed by 
an lentum strain and involved the oxidation of the 66-hydroxyl group 
of 6-muricholic acid to a 6-keto group. The 6-keto group could be sub­
sequently reduced by a Fusobacterium sp. to a 5a-hydroxy group, yield­
ing w-muricholic acid. Thus, through the concerted action of two dif­
ferent bacteria an epimerization reaction occurred. This illustrates a 
commonly observed phenomena; different end products are often detected 
in pure and in mixed cultures. Often, what appears as a stable end 
product in pure culture is further metabolized to other compounds in a 
mixed culture. 
Not all biotransformations of bile acids are carried out by intes­
tinal bacteria. Sawada et al. (121) demonstrated that the soil fungus, 
Fusarium equiseti M41, could transform lithocholic acid to ursodeoxy­
cholic acid very efficiently. 
Steroid transformation is now being proposed as a stable taxonomic 
method to differentiate different strains of bacteria. Bokkenheuser et 
al. (15) support the use of this in the differentiation for Eubacterium 
sp. (15, 43). 
The physiological effects exerted by transformed steroids are of­
ten difficult or impossible to separate from closely interrelated 
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factors, such as diet, intestinal motility, or enterohepatic circula­
tion. The effects of dietary fiber on steroid metabolism are mainly 
physical and not of microbial origin. Diets high in fiber did not 
change the total bile acids produced, but did affect their distribution 
and qualitative pattern in the small intestine and colon. 
Trans-fatty acids also affect the fecal excretion of bile acids; 
this property is of interest in light of the postulated relationship 
between cancer of the colon and dietary fat (139). It has been hypoth­
esized that a high fat diet not only changes the composition of bile 
acids but also the activity of the gut microflora. The results of var­
ious studies strongly suggest that the gut microflora is modified by 
dietary hydrogenated fats. 
Cholesterol 
The biotransformation of cholesterol (5-cholesten-36—ol) is proba­
bly the most quantitatively important in the gut (26). Cholesterol is 
characterized by a trans-junction of the A/B rings and a 5,6-double 
bond in the steroid nucleus. Many plant sterols such as B-sitosterol 
and campesterol share these structural characteristics, differing only 
in side-chain modifications. These steroids are often metabolized by 
the gut flora in the same manner as cholesterol. Roughly 400-1000 mg 
of cholesterol pass through the colon daily in a healthy, nonpregnant 
human on a "mixed western diet;" thus, a situation exists where bacte­
rial impact could be great. 
Bacterial metabolism of cholesterol is largely of a reductive na­
ture. The major by-product of microbial cholesterol metabolism is 
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coprostanol (56-cholestan-3B-ol). A minor product, coprostanone (56-
cholestan-3-one) can also be detected. Depending upon the diet, more 
than 50% of the total fecal sterols can be present in the form of 
coprostanol (89) . Germ-free animals excrete only unmodified cho­
lesterol and plant sterols (38). However, gut microbes in conventional 
animals reduce (5B-hydrogenate) the 5,6-double bond to yield the less 
well absorbed coprostanol. Many investigators believe that bacterial 
metabolism of cholesterol can have a dramatic impact on the circulating 
levels in plasma and its pool size (39, 109), even though absolute 
proof of this is lacking. 
The biohydrogenation of steroids is of particular interest be­
cause this process yields the 56-hydrogen saturated derivative, whereas 
catalytic hydrogénation (in vitro) with hydrogen almost exclusively 
yields the 5a-hydrogen saturated derivative. Two major pathways have 
been proposed for the formation of coprostanol (10, 11, 89, 115). The 
first involves the direct reduction of the 5,6-double bond. An alter­
nate pathway for the reduction of cholesterol involves a two-step mech­
anism. The initial step is the oxidation and isomerization of choles­
terol to 4-cholesten-3-one (10, 11, 89, 115). Bjorkhem and Gustafsson 
(10) demonstrated that the oxidation of cholesterol to 4-cholesten-3-one 
probably involved the removal of the 3a-hydrogen as a rate-limiting 
step. This step is then followed by isomerization of the A^-double 
4 bond to a A -double bond by a mechanism using partial transfer of a 
hydrogen from the 46-position to the 6-position (10, 11). Mammalian 
enzymes can also catalyze the conversion of 4-cholesten-3-one into 
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coprostanone (11) by the enzyme 3-oxo-A -steroid 5B-reductase. The 
bacterial form of the enzyme requires NADH, whereas the mammalian form 
requires NADPH. Both probably act by the same mechanism since both are 
highly sensitive to sulfhydryl reagents (11). The second major step in 
the biohydrogenation of cholesterol is the successive reduction to 
coprostanone and coprostanol (41). Logically, the indirect hypothesis 
for the formation of coprostanol implies a two-enzyme system (11, 115). 
Surprisingly, the direct reduction of cholesterol using no intermediate 
is thought to be a relatively minor pathway (115). 
The reduction of cholesterol to coprostanol occurs predominantly 
in the ceca in cholesterol-fed rats (79), and a number of intestinal 
bacteria obtained from cholesterol-fed rats can metabolize cholesterol 
in vitro. Similar bacteria are also in humans (119). Significant 
amounts of cholesterol were metabolized when mice were fed a diet high 
in cholesterol. When, however, the intestinal flora of mice was modi­
fied by adding sulfasuxidine or streptomycin to the diet, practically 
all the cholesterol fed was recovered in the excreta and carcass. Bac­
terial metabolism of cholesterol may represent a natural way to dispose 
of cholesterol ûi vivo (144). Similar conversions occur when plant 
sterols pass through the digestive tracts of animals. 
Many intestinal bacteria possess one or the other, but not both, 
of the enzymes involved in the reduction of cholesterol (18). Recent­
ly, Eyssen and Paramentier (41, 115) isolated a Eubacterium sp. from 
the cecum that possessed both, and is therefore quite unique. Bjorkhem 
et al. (11) suggested that this Eubacterium sp. has a 3—oxo—A^-steroid 
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56-reductase because it used a two-step mechanism to reduce the 5,6-
double bond in cholesterol. This activity depended upon the addition 
of cholesterol or similar steroids, such as campesterol, 6-sitosterol, 
and stigmasterol to the growth medium. Cholesterol was thought to be 
acting as a hydrogen acceptor. Certain structural requirements had to 
be met for hydrogénation to occur, however. When the 3-hydroxyl group 
was absent or in the a-position, or was substituted as in cholesteryl 
esters, no reduction of the double bond was observed (42). This 
Eubacterium sp. could also reduce the 3-keto groups of cholestanone 
(5a-cholestan-3-one) and coprostanone (56-cholestan-3-one) to the cor­
responding 56-hydroxyl derivative. When gnotobiotic rats which had 
been inoculated with this strain of Eubacterium sp. were cecectomized, 
this hydrogénation ceased within 2 days. 
The biohydrogenation of steroids was suppressed by diets contain­
ing high levels of lactose (41). Lactose-supplemented diets dramati­
cally increased cholesterol absorption in the rat when measured as the 
difference between cholesterol intake and excretion, and by measure­
ments of elevated liver—cholesterol concentrations. This effect may be 
due to pH, since biohydrogenation of cholesterol is inhibited at low 
pH. Wells et al. (147) offered an alternative explanation, which re­
lates to bile production. Bile excretion in rats that had been main­
tained on a lactose, cholesterol—free diet was significantly higher 
than in sucrose-fed controls. Lactose may inhibit bile acid-metabo­
lizing bacteria, which thus allows for higher reabsorption of bile 
acids. The net result would be an increased circulating bile acid pool 
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size. Higher bile acid levels would also directly favor the absorption 
of cholesterol from the intestine (147). 
Tanaka et al. (143) found that fecal bacteria from rats fed soy­
bean protein diets demonstrated an increased ability to produce copro-
stanol when compared to rats receiving casein as a protein source. The 
observed increase in biohydrogenation was attributed to soybean pro­
tein's ability to maintain higher levels of coprostanol-generating bac­
teria or bacteria with higher metabolic rats. Rats fed a liquid diet 
containing no fiber, and virtually no fat, demonstrated that the neu­
tral steroid fraction was virtually unmetabolized by the gut flora (26). 
Kobashi et al. (81) examined the effects of oral administration of 
Clostridium butyricum on the catabolism and excretion of ^^C-labelled 
cholesterol in rats. Bacterial treatments accelerated the oxidative 
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cleavage of the cholesterol side-chain in normal rats (using C-
labelled cholesterol). Clostridium butyricum was also able to sig­
nificantly affect plasma cholesterol levels in rats fed high cholester­
ol diets. Rats treated with _C. butyricum had significantly lower plas­
ma cholesterol levels compared to control rats on the same diet. Mice 
and rats on an ordinary diet (normal cholesterol) did not show a reduc­
tion in plasma cholesterol levels. Also, these bacteria were unable to 
cleave the side-chain of cholesterol vitro, suggesting that the ef­
fect is of an indirect nature. 
Although fungi and various soil microorganisms cleave the side-
chain of cholesterol, there is little evidence that bacteria isolated 
from humans share this ability (89, 101). 
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Other biologically important steroids 
Many other biologically active steroids undergo microbial trans­
formations in the intestinal tract. Among the most important are the 
steroid hormones. 
Enzymes originating from both the intestinal mucosa and from the 
intestinal flora are important in the metabolic transformation of 
estrogens during absorption (28). Such gut metabolism plays a signifi­
cant role in reducing the bioavailability of these orally administered 
compounds. The therapeutic use of drugs can affect this relationship 
and alter absorption characteristics and the nature of the flora. In 
this regard, the use of antibiotics is particularly important. Both 
natural and synthetic estrogens and progestagens are extensively ex­
creted in bile, principally as glucuronide conjugates. Normally, these 
conjugates are hydrolyzed in the gut and subsequently can undergo 
enterohepatic circulation (1, 86). The gut microflora is a major 
source of hydrolytic enzymes, especially B-glucuronidase, and treatment 
with antibiotics may interfere with the hydrolysis of steroid conju­
gates and hence reduce or eliminate steroid reabsorption from the gut. 
Estrone sulfate is a naturally occurring estrogen which is being 
widely used for the relief of menopausal and post-menopausal symptoms 
associated with estrogen deficiency. The ^  vivo importance of bacte­
rial hydrolysis of estrogen conjugates is not known, especially since 
unequivocal evidence for the intact absorption of estrone sulfate 
(without the aid of bacterial enzymes) from the proximal and distal 
small intestine has been obtained (126). In contrast, almost 
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negligible absorption of estrone sulfate from the cecum of germ-free 
rats indicates that in this region of the tract, hydrolysis of the 
sulfate by bacterial enzymes is essential for quantitative absorption 
(126). 
Contraceptive failures often occur after the administration of 
ampicillin to women (2). Most contraceptive drugs are estrogen-based, 
and as such represent an important potential for bacterial steroid me­
tabolism to influence physiology. Reductive pathways dominate the nor­
mal estrogen metabolism by bacteria in the gut. It has been observed 
that antibiotics reduce the mass of intestinal microflora, causing a 
reduction in the transformation of estrone to estradiol and an increase 
in estrone/estradiol and estrone + estradiol/estriol ratios in feces 
(2). Simultaneously, the hydrolysis of the biliary estrogen conjugates 
by bacterial g-glucuronidase is reduced causing a shift in the excre­
tion of estrogen from urine to feces, because conjugated estrogens are 
poorly absorbed from the intestine. These results thus strongly sup­
port the concept that intestinal bacteria play a significant role in 
overall metabolism of estrogens (2). 
Bokkenheuser et al. (13) demonstrated biotransformations of corti­
costeroids which involved 21-dehydroxylation. In humans, the bacterial 
metabolism of corticosteroids appears to be restricted to those corti— 
coids which undergo biliary excretion. It is believed that in the 
human gut 11-deoxycorticosterone is metabolized to corticosterone and 
11-dehydrocorticosterone by a bacterial-mediated 21-dehydroxylation. 
The presence of 21-dehydroxylated metabolites of corticoids in human 
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urine can be explained by postulating that after hepatic metabolism, 
conjugation, and biliary excretion, the biliary steroids undergo decon-
jugation and bacterial 21-dehydroxylation in the intestine, followed by 
reabsorption, and further metabolism such as reduction of the 20-ketone, 
conjugation and finally urinary excretion. Bokkenheuser et al. (13) 
state that aldosterone may also be affected in this manner. It is note­
worthy that cysteine hydrochloride was a component of most media that 
supported the growth of 21-dehydroxylating organisms. 
20-Hydroxylated metabolites of corticosteroids are found in normal 
human urine. Originally, they were thought to be formed exclusively by 
hepatic reduction of 20-keto structures during the enterohepatic circu­
lation. Winter et al. (154), however, isolated a strain of 
Bifidobacterium adolescentis from human and rat feces which has 20-
hydroxysteroid dehydrogenase activity (154). 
Some investigators have demonstrated that the side-chains of corti-
coids can be removed by intestinal microorganisms (12). Bokkenheuser 
et al. (12) isolated a Clostridium sp. from human feces that has a con­
stitutive desmolase that cleaves the side-chain of Cortisol (a C-21 
steroid) to form llB-hydroxy-4-androstene—3,17 dione (a C-19 steroid). 
A similar reaction requires desmolase (of animal origin) to convert 
C-21 steroids into the C-19 sex hormones in mammals. 
Fecal bacteria from rats and humans convert 16a-hydroxypro-
gesterone to 17a-progesterone by dehydroxylating at the 16-position 
(16). The incidence of these bacteria in humans is low and variable; 
however, in the rat, these bacteria are typically present at about 10^ 
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per gram of feces. Bacterial involvement in 16o(-dehydroxylation reac­
tions is supported by the fact that the 17a-steroid is lacking in the 
feces of germ-free rats (16). The reaction mechanism is thought to be 
similar to formation of urinary pregnanolones by the body. Calvin and 
Lieberman (20) suggested that the conversion of 15a-hydroxyprogesterone 
to 17a-pregnanolone takes place via an intermediate C-21 steroid. 
The latter steroid is metabolized both vitro and i£i vivo to 17a-
pregnanolone (20). Bokkenheuser et al. (16) believe that the same 
mechanism occurs with isolates obtained from fecal material (rat), but 
they could not detect the C-21 intermediate, possibly due to its 
transient nature. 
Glass et al. (46) demonstrated that the 16a-dehydroxylation of 
16a-hydroxyprogesterone by Eubacterium sp. 144 resulted in the produc­
tion of 17a-progesterone (46). This reaction proceeded through a A^^ 
progesterone intermediate which initially accumulated in the culture 
medium and then was reduced to 17a-progesterone. The A^^- progesterone 
reacted chemically with L-cysteine to form a water—soluble derivative. 
The appearance of 17a-progesterone was dependent on the method of media 
preparation — whether cysteine was added before or after autoclaving 
the media. When cysteine was added separately after sterilization, it 
reacted chemically with A^^-progesterone to form a water-soluble deriv­
ative. The net effect was to remove this intermediate from further 
metabolism to 17a-progesterone. 
With the rapid increase in the number of synthetic steroids now 
available and administered, a number of investigators determined if 
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these would serve as suitable substrates for bacterial transformation. 
Bokkenheuser et al. (14) isolated three intestinal strains of 
Clostridium that possessed reductases which were active upon the A-ring 
of natural steroids and synthetic progestins. Substrates metabolized 
include: progesterone, Cortisol, deoxycortisterone, and two synthetic 
steroids - norgestrel and dimethisterone. Activities in mixed and pure 
culture were found to differ markedly. Three isolates of Clostridium 
were obtained and identified as C^. paraputrificum, C^. innocuum, and 
Clostridium sp. J-1. Both mixed cultures and C^. paraputrif icum reduced 
the A-ring of natural steroids to 3a,5 6-compounds. In contrast, pure 
cultures of jC. innocuum, and Clostridium sp. J-1 converted the sub­
strates to 33,56- and 36,5a-compounds, respectively. When synthetic 
progestins were used, the mixed culture reduced them to a mixture of 
3a,56- and 36,56-derivatives; furthermore, the natural steroids were 
metabolized at much faster rates than the synthetic steroids. The 
slower metabolism of synthetic steroids and the observation of minimal 
loss of biological activity of synthetic progestins in the intestinal 
environment is attributed to the presence of an ethynyl group which 
enhances the resistance of ring-A to reducing enzymes (14). 
Many techniques have emerged to study biotransformations of 
steroids by bacteria. Most involve preliminary separations by either 
gas chromatography, thin-layer chromatography, or high-pressure liquid 
chromatography. Recently, it has been discovered that steroid trans­
formation can be monitored by a powder diffraction technique for those 
steroids which form crystals (130). Subsamples from a fermenter can be 
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analyzed for crystal growth, thus providing information on the extent 
of the transformation. 
Vitamin D 
Recently it was discovered that, in the presence of rumen bacte­
ria, vitamin D, a 9,10 seco-steroid, undergoes C-10(19) oxidation (110, 
127, 128, 129). Napoli et al. demonstrated that mixed populations of 
rumen bacteria produce 5(E)-19-nor-10-keto-vitamin Dg (lO-keto-Ds), 
5(E)-19-nor-10-keto-vitamin Dg (lO-keto-Da), and 5(E)-19-nor-10-keto-
25-hydroxyvitamin D3 (10-keto-25-0HD3) when incubated with vitamin D 3 ,  
vitamin D2, and 25-hydroxyvitamin D3, respectively (110). This also 
represents the first documentation of bacteria-metabolizing vitamin D 
(a eucaryotic vitamin). In addition, the bacterial metabolism of vita­
min D to a more polar compound parallels its metabolism in higher ani­
mals . 
Although most of the work by Sommerfeldt and colleagues (110, 127, 
128, 129) was done by using mixed cultures that originated from the 
bovine rumen, it is likely that bacteria isolated from the cecum and 
colon of monogastric animals can also metabolize vitamin D — since 
rumen bacteria are similar to many bacteria in the cecum and colon of 
monogastric animals (5). Some support for this contention is provided 
by experiments which used isolates of C^. innocuum and C^. paraputrificum 
from human feces (documented as bile acid transformer); these bacteria 
were also able to produce lO-keto-Dg (unpublished results). The 
discovery of new microbial pathways for vitamin D metabolism is 
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exciting because these bacterial products could have biological 
activity in the host animal. 
In vitro bioassays have shown that lO-keto-Dg is significantly 
more active at stimulating bone calcium resorption than the parent vi­
tamin D3 (134). However, results obtained from in vivo biological as­
says (everted gut sac technique) with lO-keto-Dg demonstrate some re­
sidual biological activity, but 40- to 80-fold less than that obtained 
with vitamin D3. Similar vitro and vivo differences in biologi­
cal activity have been shown with 10-keto-25-0H-D3. The in vivo data 
suggest that the C-10(19) oxidation is a deactivation process for vita­
min D. The discrepancy between i^ vivo and vitro results probably 
involves differences in half-life or turnover times. More research 
relating to the biological activity of these metabolites is needed to 
clarify their physiological importance. 
Pharmacologically, this new C-10(19) oxidative pathway for vitamin 
D may have particular relevance. With the current trend of supplement­
ing foods with excessive amounts of vitamin D, more is reaching the 
intestine than is physiologically required or safe (67). This condi­
tion would provide large amounts of substrate for bacteria capable of 
biotransforming vitamin D. It may be possible that, in cases of vita­
min D excess, the natural flora reduce the risks of toxicity by oxidiz­
ing vitamin D to its less active forms. Related findings from vitro 
experiments, which incubated bacteria in the presence of high levels of 
vitamin D (which may occur i^ vivo under large doses of vitamin D in­
take) , detected several other uncharacterized bacterial metabolites of 
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vitamin D. Unfortunately, the biological role of these uncharacterized 
compounds is unknown, but they should be considered seriously because 
1,25—dihydroxyvitamin D3 is active in picomolar concentrations. 
The compound lO-keto-ZS-OH-Dg has also been produced in cultures 
of kidney cells (125) and phagocytic cells (25, 85). C-10(19) oxida­
tion of the vitamin D nucleus does not, therefore, appear to be limited 
to procaryotic organisms. It is not known at this time if production 
of the 10-keto compounds in these eucaryotic systems is similar to the 
bacterial system. 
The assumption that the intestinal flora cannot significantly af­
fect the host's physiology by the transformation of intestinal steroids 
is rapidly losing support. Frequently, the flora and its host are 
treated as mutually exclusive subjects, with no acknowledgment of any 
interaction. However, the flora and its respective host evolved to­
gether in a host-symbiont relationship and, as such, should not be 
treated as disjointed units. 
Vitamin D 
Importance and implications 
This part of the literature review is not meant to be a complete 
review of the vitamin D area. It is hoped, however, that this summary 
of selected citations will provide the reader, especially those not 
intimately involved in vitamin D research, a working knowledge and an 
appreciation of this unique compound. 
Along with the two peptide hormones, calcitonin and parathyroid 
hormone (PTH), vitamin D is one of the most important biological 
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regulators of calcium and phosphorus metabolism (32, 35, 82, 83, 111). 
This field of research has undergone a staggering metamorphism in the 
last two decades (33) . Vitamin D should not be regarded as a single 
compound with a single biological activity, but as a whole family of 
compounds. Approximately 27 known metabolites of vitamin D are now 
documented, but the biological activities of only a few of these are 
known. 
The designation of cholecalciferol as vitamin D is actually a mis­
nomer, since it is now accepted that vitamin D actually functions as a 
steroid hormone (32, 35, 111). In this regard, 1,25-(OH)2D, the active 
metabolite of vitamin D, fits the classical definition of a steroid 
hormone — that is a compound produced in one organ that exerts its 
biological activity in another part of the body. Vitamin D should only 
be considered as a vitamin under conditions of insufficient light since 
only then is vitamin D required in the diet. 
The recognition of vitamin D as the antirachitic factor in foods 
is attributed to Sir Edward Mellanby (106) as early as 1919. The dis­
tribution of rickets over the world and its correlation with the inten­
sity of sunlight was recognized by Hess (57) in 1929. These two obser­
vations, that rickets was induced by a lack of sunlight or that rickets 
was induced by a lack or deficiency of a nutritional factor, as demon­
strated by Mellanby in 1921, appeared to be contradictory when first 
examined together. Mellanby (107) wrote, "The action of fats in 
rickets is due to a vitamin or accessory food factor which they con­
tain, probably identical with the fat-soluble vitamin." Furthermore, 
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to prove his hypothesis he established that cod-liver oil was an excel­
lent antirachitic agent. Huldschinsky (75) demonstrated that it was 
the ultraviolet (U.V.) spectrum in sunlight that was effective in 
increasing the degree of calcification in the epiphysis of rachitic 
infants. 
No connection was made between the curative powers of U.V. light 
and the existence of a dietary factor in cod-liver oil until the work 
of Goldblatt and Soames (47) and Steenbock and Black (131). Goldblatt 
and Soames (47) found that irradiated livers from rachitic rats became 
antirachitic when fed to other rachitic rats. Steenbock et al. (132) 
found the same effect in certain other foods which had been irradiated 
with U.V. light. What was unknown to these investigators was that two 
major forms of vitamin D exist — vitamin D2 and D3. The metabolism of 
vitamin D2 and vitamin D3 were once thought to be identical, except in 
the chick (22); however, many investigators are finding that many spe­
cies discriminate between these two major forms of vitamin D (72, 76, 
129). 
In 1932, Windaus et al. (152) identified the structure of vitamin 
D2 and showed that it was a seco-steroid. In 1936, the structure of 
vitamin D3 was chemically characterized from studies involving the U.V. 
irradiation of 7-dehydrocholesterol (153). Natural vitamin D from 
cod-liver oil was determined to be identical to vitamin D3, and 
7-dehydrocholesterol, not ergosterol, is the true provitamin of the 
"natural vitamin." Ergosterol, found in plants and yeast, is the 
provitamin for vitamin D2 (111). 
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Metabolism 
Vitamin D3 is produced by a photochemical activation of 7-hydro-
cholesterol in the skin of most higher animals (65, 66). Exogenous 
vitamin D also enters the body through the diet as either vitamin D2 
(associated with plants and yeast) or vitamin D3 (associated with ani­
mal products). Absorption of vitamin D occurs through the lymphatics 
and requires bile salts (36, 50) similar to other intestinal steroids. 
Both the vitamin D3 synthesized in the skin and the vitamin D ab­
sorbed by the gut are transported via a plasma transport protein or 
6-lipoprotein (65) to the liver where vitamin D is rapidly cleared from 
the plasma. In the liver, vitamin D is hydroxylated at the 25-posi-
tion; this step represents the major initial reaction in the activation 
process. 25-Hydroxylation is required for all subsequent metabolism of 
vitamin D (34). 25-Hydroxyvitamin D (25-OHD) is also the major circu­
lating form of the vitamin. Normal levels in humans range from 20 to 
40 ng/ml (52, 71). The mechanism for the 25-hydroxylation of vitamin D 
is thought to involve a cytochrome P-450, molecular oxygen, and NADPH 
(34, 44, 99, 155). 
Although reports of 25-hydroxylation of vitamin D in the intestine 
and kidney exist, the liver is considered to be the major organ in­
volved. After hydroxylation, the product 25-OHD is rapidly removed 
from the liver (bound to a transport protein) and is carried to the 
kidney where it subsequently undergoes further hydroxylation. 
The most important reaction occurring in the kidney (with regard 
to vitamin D) is the la-hydroxylation of 25-hydroxyvitamin D3 to 
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produce la,25-dihydroxyvitainin Dg [l,25-(OH)2D] (35, 111). The discov­
ery of la,25-dihydroxyvitamin D (the most biologically active form of 
the vitamin known) is contested between DeLuca and Norman (31, 111). 
The hydroxylase system in the kidney is similar to that found in 
the liver, as both are mixed function oxidases that require a cyto­
chrome P-450 (44, 45). The product 1,25-(0H)2D is transported to the 
target tissues in bone, intestine, and kidney. In regard to bone and 
intestinal tissue, the kidney can be considered an endocrine gland. 
1,25-Dihydroxyvitamin D can also be produced in the placenta (145, 146) 
and bone (73). However, the in vivo significance of non-renal 
1,25-(OH)2D production is unknown. 
Although considerations of the regulation of vitamin D metabolism 
are beyond the scope of this review, it should be noted that the regu­
lation and metabolism of 1,25-(0H)2D synthesis is exceedingly complex. 
1,25-Dihydroxyvitamin D is closely regulated by plasma calcium and 
phosphorus levels and the peptide hormone PTH. Interactions have also 
been documented with estrogen, calcitonin, and growth hormone (111). 
1,25-Dihydroxyvitamin D is thought to enter the cell and exert its 
biological activity by mechanisms traditionally associated with steroid 
hormones. The localization of 1,25-(0H)2D3 in target tissues is one of 
the most active areas of investigation in vitamin D metabolism (35) . 
Biochemical evidence, using subcellular fractionation and [^H]-labelled 
1,25-(0H)2D3, suggested that the 1,25-(0H)2D localized in the nuclear-
chromatin fraction before initiation of a target organ response (23). 
Specific nuclear localization of 1,25-(0H)2D3 has been reported for 
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intestinal villus cells (156), osteoblasts (136), distal renal tubular 
cells of the kidney (137), islet cells of the pancreas (24), brain 
(135), skin (136), and pituitary gland (136). 
The appearance of 1,25-(0H)2D3 in these different tissues suggests 
that 1,25-(0H)2D may have multiple functions. The numerous interac­
tions of vitamin D with hormones that traditionally have not been asso­
ciated with calcium homeostasis confirm this. 
Vitamin D can undergo numerous other reactions to produce some 27 
different metabolites. Many of these compounds probably represent in­
termediates in the degradation of vitamin D. The biological activities 
of many of these compounds have yet to be determined. 
Quantitatively, the second most important reaction that occurs in 
the kidney concerning vitamin D is the production of 24R,25-dihydroxy-
vitamin D [24,25-(OH)2D] by the action of 24R-hydroxylase (35, 80, 
141). A great deal of controversy surrounds this compound since many 
investigators believe it has an important biological role, while others 
think it has none. Norman supports the contention that 24,25-(OH)2D 
and 1,25-(0H)2D are both required for normal egg hatchability (112). 
The 24R-hydroxylase is also considered to be a mixed-function 
monooxygenase (100) like the la-hydroxylase and the 25-hydroxylase 
enzymes. Production of 1,25-(OH)2D and of 24,25-(OH)2D are 
diametrically opposed. In animals with normal concentrations of plasma 
calcium, 24-hydroxylation predominates, whereas under conditions of 
calcium demand (low plasma calcium), the la-hydroxylation becomes the 
major reaction. 
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Another dihydroxylated metabolite, 25,26-dihydroxyvitamin D 
[25,26-(0H)2D]> was discovered in pigs by Suda et al. (138). It has 
also been noted in other species (71). The exact function is not known 
(111). 
One of the most recent pathways of vitamin D metabolism to be dis­
covered involves the production of 25-0HD3-26,23 lactone (lactone) 
(149). Lactone has been found in the plasma of vitamin Dg-toxic pigs 
and cows (59, 70), rats (70, 123), and man (88). Although 25,26-(0H)2D 
was originally thought to be the precursor to lactone, later work 
clearly demonstrated that 23S,25-(0H)2D3 was the most efficient 
precursor (142). 23,25,26-Trihydroxyvitamin D represents the next 
intermediate in sequence of producing this unique compound (111). 
Horst (69) has demonstrated that the lactone binds plasma proteins with 
higher affinity than any other known vitamin D compound. 
There are several other minor metabolites of vitamin D (most 
appear in the case of excessive vitamin D intake); however, their pres­
ence should not be considered unimportant since the biological activity 
of many of these compounds is unknown. Some of the other minor 
metabolites are la,25S,26-(0H)3D3 (117), 24-oxo-25-0HD3 (140), 
23,24,25-(0H)3D3 (150), 24,25,26-(0H)3D3 (150), 24-OHD3 (150), and 
23-dehydro-25-0HD3 (150). The biological activity of these compounds 
is also unknown. 
Biological activity 
It is generally accepted that 1,25-(OH)2D represents the most bio­
logically active form of vitamin D. It also represents the most 
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studied form. The classical biological functions of 1,25-(OH)2D are: 
(a) In conjunction with PTE, it stimulates the mobilization of bone 
calcium and phosphorus. Parathyroid hormone induces a phosphaturia, so 
the net effect is an increased serum calcium concentration. (b) Al­
though still controversial, 125-(0H)2D is thought to be involved in the 
conservation of calcium by stimulating renal resorption. (c) 1,25-Di-
hydroxyvitamin D can also stimulate the transport of calcium and phos­
phorus from the intestine. (d) 1,25-Dihydroxyvitamin D is thought to 
be involved in normal egg shell development in birds (112). 
24,25-Dihydroxyvitamin D has also been extensively studied, but 
its biological activities are still the subject of controversy. 
24,25-Dihydroxyvitamin D may be involved in the following, but more 
proof is required: (a) it may be required for normal embryo develop­
ment in birds (54, 55, 111); (b) it also may play a role in bone forma­
tion (113) and maintenance (17); (c) 24,25-(0H)2D may suppress PTH 
levels and thereby influence 1,25-(0H)2D3 metabolism (56). 
Enterohepatic cycling of vitamin D 
The C-10(19) pathway for production of lO-keto-Dg may have an im­
portant physiological role, especially when one considers that mi­
crobial metabolism of vitamin D may be closely tied to enterohepatic 
recycling. As much as 30 to 40% of the major metabolites of vitamin D 
generated by host enzyme systems have been documented to travel in an 
enterohepatic cycle (8, 49, 151). When [^H]-labelled 25-OHD was in­
jected into humans, approximately one-third of the label appeared in 
the duodenum within 24 hours - via the bile (8, 48). However, fecal 
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excretion could only account for about 3% of the total radioactivity 
during the same time period, suggesting that the majority of the label 
was reabsorbed from the small intestine. This implies that the entero-
hepatic cycle is highly conservative and that the gut contains a sig­
nificant vitamin D pool. Similar results have been reported using 
1,25-(0H)2D3 (49, 152). 
Vitamin D seems to mimic bile with regard to its enterohepatic 
recycling, possibly due to structural similarities (48). Like bile, 80 
to 90% of vitamin D and its metabolites are resorbed in the jejunum. 
With the evidence for bacterial transformation of steroids in the gut, 
substantial support also exists for the biotransformation and absorp­
tions of vitamin D. It has been shown that lO-keto-Dg can be detected 
in both the plasma and rumen of a cow receiving large internal doses of 
vitamin D (127). The enterohepatic cycle may act as a regulator which 
controls the circulating levels of the various metabolites, as noted by 
the rapid removal of 1,25-(0H)2B3 shortly after injection (49, 152). 
Naturally, any gastrointestinal disease (8) or bacteria which can in­
terrupt the recycling of 25-OHD should be considered as a factor which 
would limit the availability of vitamin D. 
Requirements and toxicity 
The unique nature of vitamin D that allows both endogenous synthe­
sis and dietary supplementation to occur simultaneously can create a 
potentially harmful situation. Substantial evidence has accumulated to 
suggest that there is a narrow tolerance between the amounts needed and 
that which may produce deleterious results (67). 
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Most animals, including humans, that are not totally confined re­
ceive adequate sunlight which will provide enough vitamin D to meet 
their requirements. There is also an increasing tendency to supplement 
both animal and human foods with higher levels of vitamin D. This, in 
conjunction with the "fad" of taking mega doses of vitamins, can result 
in dramatic consequences. Many investigators believe that intakes of 
vitamin D often far exceed the official recommendations and greatly 
exceed the physiological requirement of the body (122). Emphasis 
should be placed on how best to protect against rickets without devel­
oping associated risks of accentuating or causing cardiovascular and 
renal disease (122). Practices that result in supplying excessive 
amounts of vitamin D (either directly from supplemented foods for human 
consumption or foods derived from animals that consume supplemented 
feeds) can result in vitamin D toxicity to a proportion of the popula­
tion. These practices require reexamination (44, 67, 122). 
Like the other fat-soluble vitamins, vitamin D can accumulate in 
fatty tissues; it is then slowly released back into the blood stream 
regardless of the physiological needs of the animal. Excessive levels 
of vitamin D are toxic. The major symptom associated with vitamin D 
toxicity is primarily soft tissue calcification. 
In humans, the actual requirement for vitamin D is not known, but 
based on information that a supplement of 2.5 yg of vitamin D3 (0.025 
pg of vitamin D3 equals 1 international unit [I.U.]) prevents rickets 
and ensures adequate calcium absorption (67), the current recommended 
levels in humans are 400 I.U. per day. The National Academy of 
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Sciences has established the National Research Council which prescribes 
the recommended dietary nutrient requirements (including vitamin lev­
els) for all the major forms of livestock and pets. The amount of vi­
tamin D recommended varies with species, age, type of housing, and 
phase of reproduction. 
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SECTION I. 
FACTORS AFFECTING THE PRODUCTION OF 5(E) 19-NOR-lO-KETO-VITAMIN D3 
BY RUMEN BACTERIA 
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INTRODUCTION 
Bacteria in the gastrointestinal (GI) tract are known to play an 
active role in altering the structure and function of many endogenous 
and dietary steroids (11, 12, 19). Previous research with bacterial 
steroid transformations has focused on the three major classes of 
steroids passing through the GI tract; these include cholesterol (8, 
13, 31, 32), steroid hormones (6, 7, 33), and the bile acids (1, 19, 
21, 22). Similarly, groups in Ames, lA, and Dallas, TX, collaborated 
in demonstrating that cholecalciferol (vitamin D3), a 9,10 seco-steroid, 
undergoes C-10(19) oxidation when incubated in vitro with strained bo­
vine rumen fluid (24, 29, 30). They isolated and identified the com­
pounds 5(E)-10-keto-19-nor-vitamin D3 (lO-keto-Dg), and 5(E)-lO-keto-
19-nor-25-hydroxyvitamin D3 (10-keto-25-0H-D3) from incubations with 
vitamin D3 and 25-hydroxyvitamin D3, respectively (24). In this sys­
tem, up to 75% of the [^H]-vitamin D3 was converted into polar metabo­
lites; 10-keto-[^H]-D3 was the major product (24). These compounds 
could not be detected in incubations with sterile rumen fluid, thus 
implying that bacterial metabolism was involved in their production. 
Although the vivo significance of 10—keto-D3 production has yet 
to be determined, the discovery of its vitro production by microbes 
may have special relevance because several vitamin D sterols, including 
vitamin D3, 25-hydroxyvitamin D3, and 1,25-dihydroxyvitamin D3 [the 
latter two are major products of host metabolism of vitamin D3] (25), 
circulate in the enterohepatic cycle of mammals and therefore may be 
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available for oxidation by gut bacteria (3, 16). Also, the recent 
finding that lO-keto-ZS-OH-Dg is produced by kidney cell lines (28) and 
phagocytic cells (10, 17) established that eucaryotic systems can 
affect this oxidative pathway as well. 
Little is known about the pathway leading to the production of 
lO-keto-Dg by bacteria. However, given the potential vivo impor­
tance of this oxidative pathway, the present vitro studies were con­
ducted to identify conditions required for the optimum production of 
lO-keto-Dg, and to characterize the processes involved. This report 
establishes that oxygen, pH, and reducing agents are of primary impor­
tance in the expression of the C-10(19) oxidative pathway for vitamin 
D. 
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MATERIALS AND METHODS 
General 
High-pressure liquid chromatography (HPLC) was performed with a 
Waters Model LC-204 chromatograph fitted with a Model 6000-A pump and 
Model 440 fixed-wavelength (313 nm) detector (Waters Associates, 
Milford, MA). HPLC columns (0.46 x 25 cm) were purchased from DuPont 
Instruments (Wilmington, DE), unless otherwise noted. Normal phase 
refers to microparticulate silica gel columns. Reverse phase refers to 
microparticulate silica gel columns derivatized with octa decylsilane 
(ODS). Spectral-grade solvents (Burdick and Jackson, Inc., Muskegon, 
MI) were used in all chromatography systems. The U.V. spectra were 
obtained in ethanol by using a recording spectrophotometer (Model 25, 
Beckman Instruments Co., Lincolnwood, IL). A molar extinction coeffi­
cient of 27,000 was used for lO-keto-Dg. 
Steroids 
Vitamin D3 was purchased from Sigma Chemical Co. (St. Louis, MO). 
[3a-^H]-Vitamin D3 (1.2 Ci/mmole) was prepared by the sodium boro-[^H]-
hydride reduction of the a-tricarboxyliron complex of 3—keto-vitamin D3 
(4). Radiochemical purity was confirmed by normal-phase HPLC by using 
hexane/isopropanol (99/1) at a flow rate of 2 ml/min. The lO-keto-Dg 
used for standards was a gift from Hoffmann-La Roche, Inc. (Nutley, 
NJ). All lO-keto—[^H]-vitamin D3 (1.2 Ci/mmole) used as internal stan­
dards was prepared from [^H]-vitamin D3, as described by Napoli et al. 
(24). 
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Enzymes 
Superoxide dismutase (SOD) and catalase were purchased from Sigma 
Chemical Co.; both enzymes originated from bovine liver extracts. The 
specific activity of the SOD and catalase preparations were 2500 
units/mg protein and 11,000 units/mg protein, respectively. 
Extraction and Chromatography 
Two extraction and chromatographic techniques were used. The 
first (System I) was employed to define the conditions required for 
maximum production of lO-keto-Dg. Samples were extracted for total 
lipids (5) and applied to a Lipidex (Packard Instrument Co., Inc., 
Downers Grove, IL) 5000 column (0.9 x 20 cm). The column was developed 
in a two-step elution sequence (Fig. 1). The lO-keto-Dg eluted follow­
ing the change of solvent from 10% chloroform in hexane to 50% chloro­
form in hexane. 
A second chromatographic system (System II) was used for quantita­
tive analyses. This method involved a solid-phase extraction technique 
using C^g "Sep-Paks" (Waters Associates). Following an incubation, 30 
ml of acetonitrile were added to 20 ml of either strained rumen fluid, 
a culture of rumen bacteria in Brain Heart Infusion (BHI) (BBL Labora­
tory Systems, Cockeysville, MD), or a cysteine'HCl solution. To moni­
tor recovery, 10,000 dpm of 10-keto-[^H]-D3 was added to each serum 
bottle. The mixture was placed on a shaker for 20 min and then trans­
ferred to a 50-ml conical centrifuge tube. After centrifugation (2000 
X g for 10 min), the supernatant was decanted into a clean serum bottle 
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(100 ml) containing 20 ml of water. The entire 70 ml was passed 
through a C^g Sep-Pak, followed by 3 ml of (70/30) methanol/water. The 
lO-keto-Ds fraction eluted with 8 ml of (90/10) acetonitrile/water, and 
was collected and dried under nitrogen. The residue was dissolved in 
50 ul of (98/2) hexane/isopropanol, and applied to a Waters silica 
Sep-Pak. The eluate, 8.5 ml of (98/2) hexane/isopropanol, contained 
the vitamin D3 fraction. The addition of 8 ml of (90/10) hexane/iso­
propanol was required to elute lO-keto-Dg. This fraction was col­
lected, dried under nitrogen, and prepared for reverse-phase HPLC by 
redissolving in 200 pi (90/10) methanol/water. Reverse-phase HPLC was 
accomplished in (90/10) methanol/water at a flow rate of 2 ml/min. 
lO-Keto-Ds eluted at 32 ml in this system. The lO-keto-Ds peak was 
collected, dried and analyzed for radioactivity with a Beckman LS-9800 
liquid scintillation counter. All reported values were corrected for 
quench and recovery of the 10-keto-[^H]-D3. 
Preparation of Media 
All manipulations were done anaerobically, as described by Hungate 
(18), except that cysteine'HCl was added to the media, and the media 
were dispensed (20 ml) into 100-ml serum bottles prior to steriliza­
tion. The basal medium consisted of BHI broth supplemented with 
(wt/vol) 0.05% cysteine'HCl, 0.1% resazurin, 0.3% arginine, and 0.4% 
NazCOg. Basal medium supplemented with 1.0% (wt/vol) glucose was used 
to determine if glucose inhibited the production of lO-keto-Dg. All 
media were adjusted to pH 6.8, and anaerobically dispensed under 
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02-free COg. Cultures were transferred between serum bottles by using 
syringes which were pre-gassed with anaerobic CO2. 
Assay Conditions 
All cultures in BHI broth were grown overnight before being 
assayed for their ability to produce 10—keto-Dg. Incubations were 
conducted in 100-ml serum bottles to accommodate rapid atmospheric 
changes. This was accomplished by inserting gas lines with needle 
attachments through the butyl-rubber stoppers. Rumen fluid 
incubations, and mixed cultures derived from rumen fluid, were 
performed under an atmosphere of 10% O2 in CO2. Cultures of the 
ruminai isolate of Clostridium sp. strain A264 required a lower O2 
concentration (4%), since higher levels were inhibitory. The O2/CO2 
mixture was obtained by using a dual flow meter (Matheson Co., Inc., 
Rutherford, NJ). The concentrations of O2 and CO2 were measured by 
using a Loenco respiration and blood gas analyzer (Altadena, CA). All 
incubations were conducted at 39°C. 
Rumen Fluid Studies 
Samples of rumen fluid were obtained from a nonlactating, nonpreg­
nant, fistulated Jersey cow fed a maintenance diet of 90% alfalfa hay 
cubes and 10% cracked corn. The samples were taken 4 to 5 h after 
feeding, strained through 4 layers of cheesecloth, and used within 30 
min. 
53 
Oxygen studies 
The effects of varying O2 concentration on lO-keto-Dg production 
were performed exclusively in strained rumen fluid containing 1 x 10^ 
dpm of [^H]-vitamin Dg. The impact of different atmospheres was as­
sessed by overlaying the rumen fluid with the desired concentration of 
O2 (0-10% in CO2 or room air). One set of bottles was sealed with 
butyl-rubber stoppers (closed system), and another set of bottles was 
closed with cotton stoppers (open system). The effects of shaking were 
studied at a speed of 132 oscillations/min. Bubbling experiments using 
gas mixtures were performed in Pyrex test tubes (2.5 x 21 cm). All 
bottles and tubes were incubated 20 h at 39°C. System I was used for 
extraction and chromatography, as previously described. 
Preincubation treatments 
To ascertain the importance of viable cells in the transformation 
of vitamin D3 to lO-keto-Dg, both sterilized (121°C for 15 min) and 
cell-free rumen fluid samples (10,000 x g for 20 min followed by fil­
tration through a 0.45 ym Millipore filter) were prepared. These two 
treatments, and an unmanipulated control, were incubated under static 
(no shaking) conditions with an atmosphere of 10% O2 in CO2. The reac­
tion was initiated with the addition of 1 x 10^ dpm of [^H]-vitamin D3. 
System I was used for extraction and analysis. 
Mixed Culture Studies 
Cultures of mixed rumen bacteria were maintained in BHI broth and 
transferred (0.5% inocula) every 3 days. To conduct an assay, a 
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culture was incubated overnight under COg, the atmosphere was then 
changed to 10% 0% in CO2, and the reaction was initiated by the addi­
tion of 400 ug of vitamin D^. After a 4-h incubation, the presence of 
lO-keto-Ds was determined by using System II. 
Filtration 
A mixed culture was grown overnight in 500 ml of BHI broth and 
then heat-killed (121°C for 15 min). Three 20-ml portions were taken 
and anaerobically dispensed into serum bottles to serve as controls. A 
300-ml sample was clarified by centrifugation at 10,000 x g for 20 min. 
Two hundred ml of supernatant were filtered through an Amicon PM-10 
62-mm filter (10,000 M.W. cutoff). Three 20-ml portions of the fil­
trate were removed for analysis. The Amicon "retentate" was resus-
pended in 100 ml of sterile BHI broth, and divided into two 50-ml 
aliquots. One aliquot was combined with 50 ml of sterile BHI broth; 
the other was combined with 50 ml of filtrate. Three 20-ml subaliquots 
were taken out of each mixture and anaerobically dispensed into each of 
3 serum bottles. Four hundred pg of vitamin D3 in 50 ul ethanol were 
added to each of the 15 bottles. The bottles were incubated under an 
atmosphere of 10% O2 in CO2 for 20 h, and then the presence of 
10—keto-Ds was determined by using System II. 
Time study 
The production of lO-keto-Dg was plotted against time (0 and 7 h); 
analysis was by System II. Production peaked at 4-5 h; thus, a 4-h 
incubation period was used for subsequent studies. 
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Glucose inhibition 
Mixed cultures were grown under CO2 for 20 h in basal medium and 
basal medium plus 1.0% glucose. At the end of this incubation period, 
the atmosphere was changed to 10% O2 in CO2, and the reaction was ini­
tiated by the addition of 400 pg of vitamin D3. The bottles were incu­
bated for 4 h, after which the pH was measured. Extraction and analy­
sis was by System II. 
Isolation of Clostridium sp. Strain A264 
Mixed cultures grown in BHI were heat-shocked at 80°C for 15 min, 
and transferred into fresh BHI broth. The resulting suspension was 
then streaked for isolation on BHI roll tubes (2% agar). After incuba­
tion, colonies were picked and assayed for their ability to produce 
lO-keto-Dg. All isolates were morphologically similar; one strain, 
A264, was selected for further studies. The culture was maintained on 
BHI slants (BHI broth + 1.5% agar) and transferred weekly. Identifica­
tion was as described by the Anaerobic Laboratory Manual, Virginia 
Polytechnic University (Blacksburg, VA). 
Pure Culture Studies 
These studies used identical media and growth conditions as de­
scribed in the "Mixed Culture" section. Cultures were grown overnight 
in BHI broth under CO2, the atmosphere was then changed to 4% O2 in 
CO2, and the reaction was initiated by the addition of 400 ug of vita­
min D3. The atmosphere used in these pure culture studies had a lower 
O2 content because higher levels were inhibitory to the production of 
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lO-keto-Ds by this bacterium. System II was used for extraction and 
chromatography. 
Glucose inhibition studies 
These were done as previously described for the mixed cultures. 
Cysteine Studies 
Solutions of cysteine'HCl (0.1% wt/vol) were made with spectral 
grade water, and the pH was adjusted to 7.0. Prior to dispensing (20 
ml/serum bottle) and sterilization, the solutions were bubbled with 
Oz-free Ng gas to remove traces of Og. For assay, a serum bottle was 
injected with 500 yg of vitamin D3 in 50 pi ethanol followed by 2 ml of 
O2. Incubations were under static conditions. At the end of 4 h, the 
samples were extracted and chromatographed by using System II, except 
that no centrifugation step was used. The effect of catalase (1000 
units/ml) and SOD (500 units/ml) were studied by using the same 
cysteine'HCl solution. The enzymes were introduced into the serum bot­
tles in 150 lil of anaerobic water carrier. As controls, the enzymes 
were denatured by heating them at 100°C for 5 min prior to injection. 
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RESULTS 
Rumen Fluid Studies 
In initial studies with strained rumen fluid, an elaborate chro­
matographic system (System I) was used because rumen fluid contains a 
variety of lipids and particles. Recoveries of 10-keto—D3 were low, 
and the sensitivity of System I was poor compared to System II. 
We extended the earlier work of Sommerfeldt et al. (29) by demon­
strating that production of lO-keto-Dg by mixed microbial populations 
(strained rumen fluid) required molecular O2. As shown in Tables 1 and 
2, the ability to produce lO-keto-Dg was affected by the atmosphere and 
incubation conditions. The production of 10—keto-Dg was negligible 
under strictly anaerobic conditions; however, atmospheres which con­
tained low levels of O2 were stimulatory. When 0% concentrations were 
too high (open system), production was diminished, although to a lesser 
degree, than with total anaerobiosis (Table 1). 
Variations in O2 concentration, and the method used to introduce 
O2» demonstrate that in the 100-ml serum bottle system which relied on 
diffusion (static), the optimal atmospheric O2 concentration was 
approximately 10% (Table 2). However, since these results were 
obtained under conditions where an O2 gradient was formed, the active 
region for lO-keto-Dg production within this gradient (or the effective 
oxygen concentration) is not known. Rapid O2 introduction by shaking, 
dramatically reduced the amount of lO-keto-Ds formed. Production of 
10—keto-Dg in the shaking system peaked at 4% O2, but the yield never 
approached that of the static system using 10% Og. When gas mixtures 
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containing between 1.22 and 0.10% Oz in COz were bubbled through rumen 
fluid, total inhibition of 10—keto-Dg formation was observed (data not 
shown). 
The extent of anaerobiosis (static vs. shaking) was estimated by 
monitoring methane production after incubation in closed systems (Fig. 
2). Under static conditions, even with a 10% oxygen head space, parts 
of the serum bottle (presumably at the bottom) were still highly an­
aerobic, as indicated by the high concentrations of Oz required to in­
hibit methane production. The lowest level of O2 used (2%) reduced 
methane production in the shaking system. 
Heat-sterilized rumen fluid did not support the production of 
lO-keto-Dg (Table 3). When rumen fluid was clarified by centrifugation 
at 10,000 X g, 10-keto—D3 formation was greatly reduced, indicating 
that viable cells were needed for maximal conversion of vitamin D3 to 
lO-keto-Dg. However, slow speed centrifugation (1000 x g) to remove 
large particles and protozoa did not significantly reduce the amount of 
10-keto—D3 in the supernatant (data not shown), suggesting that bacte­
ria play the main role in the formation of lO-keto-Dg. Resuspension of 
the pellet in the supernatant restored 10—keto-Dg production to levels 
nearly equivalent to those obtained in unmanipulated samples. 
BHI Broth Culture Studies 
The extraction and chromatography of System I was simplified after 
it was discovered that the microorganisms responsible for lO-keto-Dg 
production could be cultured in BHI broth. Time-course studies (Fig. 
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3) revealed that mixed cultures in BHI broth produced lO-keto-D^ 
rapidly. Production reached a maximum level between 4 and 5 h, com­
pared with rumen fluid which required 18 to 20 h incubation (J. L. 
Sommerfeldt, Ph.D. Dissertation, Iowa State University, Ames, lA). 
During attempts to isolate a bacterium which could catalyze the 
production of 10-keto—D3, we observed that the ability to produce 
lO-keto-Ds was not destroyed upon heat treatment (Table 4). This sug­
gested that a spore-forming organism was responsible. From heat-
shocked cultures we isolated a gram-positive rod which produced 
lO-keto-Dg, and upon further examination, strain A264 was determined to 
be a member of the genus Clostridium, possibly C_. hastiforme. When 
compared to mixed cultures from the bovine rumen, this organism was 
less efficient at producing lO-keto-Dg (Table 5), possibly because the 
optimal concentrations of O2 required for lO-keto-Dg production by 
Clostridium sp. strain A264 were not known. Both mixed and pure cul­
tures produced significantly more (P < .05) lO-keto-Dg (20-fold) than 
sterile, uninoculated BHI broth. 
It is not known how unique C-10(19) oxidation is among bacteria. 
Experiments with other Clostridia demonstrated that several other spe­
cies could also catalyze production of this compound (data not shown). 
Highly active species included C^. bif ermentans, C^. sporogenes, C^. 
pasteuranium, C^. hastif orme, and C_. tetanomorphum. Those species dem­
onstrating little ability to produce lO-keto-Dg include C. 
paraputrificum, _C. innocuum, C^. butyricum, C^. septicum, and C. 
perfringens. 
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The addition of glucose to medium inhibited the production of 
lO-keto-Dg. This effect is probably attributable to acid production 
which lowered the pH of the media, rather than to a lack of 0% (Table 
5). Support for this contention is provided by results obtained with 
Clostridium sp. strain A264. Inhibition (P < .05) was noted, in the 
production of lO-keto-Dg obtained in pure or mixed cultures grown in 
basal medium plus 1.0% (wt/vol) glucose, when compared to cultures 
grown in basal medium without glucose. Clostridium sp. strain A264 can 
utilize glucose; however, it is also highly proteolytic, which dimin­
ishes its tendency to lower the pH. Being a strict anaerobe argues 
against the stimulation of oxygen uptake by the addition of increased 
substrate. The mixed culture lowered the medium pH from 6.8 to 5.2 
when BHI was supplemented with 1.0% (wt/vol) glucose. The amounts of 
lO-keto-Dg obtained with mixed cultures grown in the presence of 1.0% 
(wt/vol) glucose were not significantly different from those produced 
in sterile, uninoculated BHI broth (Table 5). 
When cultures were grown overnight in BHI broth, and then heat 
killed, the ability to catalyze lO-keto-Dg production increased dramat­
ically (Table 4). Levels of lO-keto-Dg were 10 to 12 times higher than 
those obtained with viable cells, and approximately 230 times greater 
than those obtained by nonspecific oxidation in sterile, uninoculated 
BHI broth. Attempts to fractionate the vitamin D3 oxidase activity 
from heat-killed samples revealed that at least two factors of bac­
terial origin were responsible for the observed increase in oxidative 
potential (Table 4). The first factor is smaller than 10,000 
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daltons, the second was larger than 10,000 daltons. Neither the 
filtrate nor the "retentate" alone could approach the values obtained 
in an unmodified system. Values obtained with supernatant from 
heat-killed cultures were slightly lower than when a complete system 
was used with cells. 
Production of 10-keto—D3 in a chemically-defined, nonbiological 
system revealed that cysteine was probably responsible for the produc­
tion of lO-keto-Da in sterile medium (Table 6). The effect of 0.1% 
cysteine was more pronounced in water than in a complex medium. The 
product obtained by this method had an identical E and E . as au-
max mxn 
thentic lO-keto-Dg and the biologically-produced compound (Fig. 4); it 
also comigrated on three separate HPLC systems with authentic lO-keto-
D3. The addition of a solution containing both catalase (1000 
units/ml) and SOD (500 units/ml) markedly reduced (P < .05) the ability 
of this system to oxidize vitamin D3 (Table 6) . T'Then heat-inactivated 
enzyme was used, about 60% of the ability to produce lO-keto-Dg was 
restored. 
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DISCUSSION 
In light of the anaerobic environment in the rumen, the participa­
tion of O2 in the production of lO-keto-Dg was a surprising result; 
however, several investigators have noted a stimulatory effect of O2 on 
bile acid oxidation by anaerobic bacteria (2, 20, 21). As in our stud­
ies, the mechanism of oxidation and the concentration of O2 needed were 
ill defined. Macdonald et al. (20), however, did propose a possible 
mechanism, and they suggested that formation of 3-keto derivatives of 
bile acids may simply relate to an increased ratio of intracellular 
NADP'*'/NADPH which would result from increased Eh values. Although the 
stimulatory effect of 0% was most dramatic vitro (with rumen fluid 
and cultures derived from rumen inocula grown in BHI), the availability 
and effects of O2 vivo is not known. The dissolved O2 concentration 
required for lO-keto-Dg formation must be very small because optimal 
yields were obtained when O2 entered by diffusion. Experiments in 
which low levels of oxygen were bubbled through the medium demonstrated 
that lO-keto-Da production was inhibited by low levels of O2, not by 
the lack of O2 due to facultative removal. The use of methane produc­
tion as an indicator of anaerobiosis supported the concept that the 
diffusion system still contained anaerobic areas. It appeared that O2 
could also be inhibitory to this reaction, as noted by the experiments 
with shaking and those using a pure culture of Clostridium sp. strain 
A264. Experiments in which O2 was bubbled into strained rumen fluid 
also demonstrated that rapid O2 introduction was inhibitory to lO-keto-
D3 formation. As low as 0.1% O2 was inhibitory in strained rumen fluid 
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incubations. If O2 is obligately linked to the ^  vivo formation of 
lO-keto-Dg, it could be argued that this reaction might occur at the 
epithelial surface in the gut where O2 is available (27). 
During the course of studying lO-keto-Dg production in mixed cul­
tures, we observed that 10-keto—D3 could be produced spontaneously in 
sterile uninoculated BHI broth (Table 5). This phenomenon was unde­
tected in rumen fluid incubations, presumably because of the relative 
insensitivity of chromatographic System I and the trace amounts of sub­
strate converted. lO-Keto-Dg formation, therefore, does not appear to 
be enzymatic in nature, but results from indirect effects of bacterial 
metabolism. This contention is supported by our studies showing sig­
nificant lO-keto-Ds production by heat-killed mixed cultures in BHI 
broth. Not many enzymes can survive autoclaving. Results obtained 
with the chemical production of lO-keto-Dg, using cysteine'HCl (0.1% 
wt/vol), also provide support for this assertion. 
The formation of lO-keto-Dg by anaerobic bacteria may involve the 
generation of superoxide anions, hydrogen peroxide, or other oxidative 
radicals. These compounds are among the strongest oxidizing agents 
known (14, 23). A role for hydrogen peroxide or superoxide anion in 
lO-keto-Dg production was supported by experiments in which the addi­
tion of catalase and SOD inhibited vitamin D3 transformation. Carlsson 
et al. (9) proposed a mechanism for the appearance of these agents. 
Their work showed that anaerobically prepared BHI broth can undergo 
autoxidation to produce hydrogen peroxide and superoxide anions. The 
active components in media which produce these radicals are thought to 
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involve glucose and phosphate. After they had been autoclaved together 
in media at a neutral pH, they rapidly autoxidized and ultimately 
formed superoxide radicals and hydrogen peroxide (9). Hydrogen 
peroxide is the major radical produced. The potential also exists for 
hydrogen peroxide to react with superoxide anions to form hydroxyl 
radicals (23). Autoxidation of cysteine is known to result in the 
formation of hydrogen peroxide (26). Frolander and Carlsson (15) 
demonstrated an increased toxicity of anaerobic media exposed to 
oxygen. In their studies, the addition of SOD to anaerobic media 
exposed to oxygen significantly decreased the toxicity of the media, 
confirming the presence of oxidative radicals. Nyberg et al. (26) 
stated that the rate of hydrogen peroxide formation from the 
autoxidation of cysteine could not be higher than 1 nmol/ml per min in 
a reaction mixture containing 260 uM cysteine. However, this level of 
production was more than sufficient to be toxic to Peptostreptococcus 
anaerobicius. This low rate of peroxide release could explain why our 
nonbiological system required incubation for 4 h or longer to effect 
maximal formation of lO-keto-Dg from vitamin D3. 
The results of high-pressure filtration studies suggested that at 
least two heat-stable factors that affect lO-keto-Dg production are 
released upon disintegration of the bacterial cell. Together, these 
factors apparently are capable of generating oxygen radicals which re­
sult in the formation of lO-keto-Dg. This mechanism is similar to that 
of the nonbiological system (cysteine'HCl), except that the bacteria 
probably produce some factor(s) more potent than cysteine. Production 
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of lO-keto-Ds in the nonbiological system was higher than those pro­
duced in sterile medium which contained a similar concentration of 
cysteine. One possible explanation for this observation is that in 
sterile media many other components can compete for the oxidative radi­
cals produced. In the nonbiological system, vitamin Da experiences 
less competition for oxidation, which is ultimately expressed in the 
form of enhanced lO-keto-Dg formation. On this basis, the biological 
system must be more active than the chemical system because a complex 
medium such as BHI broth contains large amounts of components which can 
compete for free radicals. 
In our experiments, glucose was inhibitory to lO-keto-Dg formation 
(Table 5). Several other investigators describe inhibitory effects of 
carbohydrates on the biotransformation of steroids by gut bacteria (12, 
21). They concluded that the observed inhibition was caused by a low­
ering of the pE. The same mechanism is probably responsible for the 
inhibition of lO-keto-Dg production in basal medium supplemented with 
glucose. Clostridium sp. strain A264 is highly proteolytic and tends 
to keep the medium around neutrality. Since this species is a strict 
anaerobe, it would not use O2 for glucose metabolism, negating the idea 
that insufficient O2 was available for vitamin D3 oxidation in medium 
containing 1% glucose. The mixed culture, on the other hand, contained 
organisms which produced acidic end products; the lowering of the pH 
was paralleled by inhibition of lO-keto-Dg production. 
Although 10-keto—D3 formation may be a nonenzymatic process, the 
production of lO-keto-Dg is unquestionably potentiated by the presence 
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of bacterial cells. As shown in Table 4, a 100-fold increase in the 
formation of lO-keto-Ds took place when cell products were present. 
This nonenzymatic metabolism of vitamin D3 by bacteria may be important 
in vivo. lO-Keto-Dg has been detected in the plasma of calves 
receiving oral doses of [^H]-vitamin D3 (30). The 10-keto-derivative 
of 25-OHD3 (10-keto-19-nor-25-0H-D3) has also been produced by cultured 
kidney and phagocytic cells (28). The mechanism by which these 
eucaryotic cells produce 10-keto derivatives of vitamin D is probably 
similar to that used by bacteria. Interestingly, both phagocytic cells 
and the P-450 cytochrome produce significant amounts of oxidative radi­
cals as a result of normal metabolism. 10-Keto-25-0H-D3 is also of 
interest because HPLC using silica gel columns with hexane/iropropanol 
solvents do not discriminate it from 1,25-dihydroxyvitamin D3, the most 
biologically active form of the vitamin (25). 
If the production of lO-keto-Ds by bacterial-mediated oxidation is 
important i^ vivo, it would probably be so only under circumstances 
where the animal is challenged by large quantities of vitamin D. In 
this situation, based on the biological assays of Napoli et al. (24), 
C-10(19) oxidative metabolism of vitamin D may benefit the host by re­
sulting in the removal of excess vitamin D from the circulation. 
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Figure 1. An elution profile from a Lipidex 5000 column of the total 
lipid extract taken from rumen fluid incubated with [^H]-
labelled vitamin D3 for 18 h. A 4% oxygen atmosphere was 
used. The Lipidex column was eluted with 50 ml of 
hexane/chloroform (9/1), followed by 100 ml of hexane/ 
chloroform (1/1) 
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Figure 2. The inhibition of methane production by oxygen in the static 
and shaking incubation systems. Methane production was used 
as an indicator of anaerobiosis 
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Figure 3. Quantities of 10—keto-Dg produced by a mixed culture of 
rumen bacteria in anaerobic BHI broth. Each point repre­
sents the mean of three replications 
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Figure 4, U.V. spectra of authentic lO-keto-Dg and that produced 
by the oxidation of D3 catalyzed by bacteria and the auto-
oxidation of cysteine ( ). Vitamin D3 absorbs maximally 
at 264 nm, whereas the 10-keto derivatives of D have an E 
at 312 nm, indicating disruption of the triene double bonS^ 
system in D 
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Table 1. The effects of different atmospheres on the production of 
lO-keto-Dg in rumen fluid (in vitro) 
Atmosphere % of total radioactivity in peak Q 
(lO-keto-Dg) 
Nitrogen 2 
Argon 1 
Hydrogen 1 
Room air (open system) 18 
Room air (closed system) 34 
10% O2 + 90% CO2 46 
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Table 2. A comparison of two incubation systems: The relationship of 
oxygen and lO-keto-Dg production in strained rumen fluid 
Initial oxygen 
concentration 
of gas phase 
(%) 
Ratio of radioactivity 
recovered in peak Q 
vitamin D3 peak 
Water bath Shaker 
% oxygen remaining^ 
after incubation 
(18-20 h) 
Water bath Shaker 
0 0.19 0.12 0 0 
2 0.63 0.21 0.24 0 
4 0.97 0.32 0.90 0 
6 2.52 0.27 1.80 0 
10 6.37- 0.18 3.80 0 
20.9 1.48 0.10 Not determined 
(Room air) 
^In gas phase. 
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Table 3. Comparison of preincubation treatments of rumen fluid on 
lO-keto-Dg production 
Treatment^ % of total radioactivity in peak Q 
(lO-keto-Ds) 
None (control) 54.0 
Heat sterilized 0 
Supernatant obtained by 
centrifugation at 10,000 x g 8.0 
Supernatant obtained by 
centrifugation at 10,000 x g 
and filtered through a 0.45 
vm Millipore filter 16.0 
Resuspension of pellet from 
centrifugation step back 
into supernatant 47.0 
^Incubations were under an atmosphere that was 10% O2 in CO2 at 
the start of incubation. 
^All values are corrected for background. Extraction and chroma­
tography were by System I. 
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Table 4. Fractionation of vitamin Dg oxidase activity from 
heat-killed mixed cultures in BHI broth^ 
Amount of lO-keto-Dg produced in 
Treatment 20 h (ng) 
Prior to centrifugation 
Uninoculated sterile BHI broth 93 ± 32^ 
Mixed culture grown for 18 h in 
BHI broth and heat killed 22,060 ± 343 
After centrifugation^ 
Filtrate <10,000 M.W. (supernatant 
passed through a 10,000 M.W. 
filter) 9,512 ± 121^ 
Resuspension of "retentate" 
(>10,000 M.W.) into sterile 
uninoculated BHI broth 764 ± 76 
Resuspension of retentate 
(>10,000 M.W.) with the 
filtrate (<10,000 M.W.) 18,206 ± 2501 
^All incubations used 400 yg D3 and 10% 0%. 
^Values with the same letter are not statistically different 
(P < 0.05). 
^The next 3 treatments all use supernatant obtained from a heat-
killed culture grown in BHI broth. These treatments were performed 
prior to the addition of vitamin D3. 
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Table 5. Comparison of C-10(19) oxidase activity in mixed and pure 
cultures - grown in basal BHI and basal plus 1% glucose 
Treatment^ 
Amount of lO-ketogOg 
produced in 4 h 
(ng) 
Final pH of medium 
(after incubation) 
Sterile uninoculated 
basal BHI 103 43A 6.80 
Mixed culture grown in 
basal BHI 2638 236^ 6.90 
Mixed culture grown in 
basal + 1% glucose 94 ± 22^ 5.20 
Clostridium sp. strain 
A264 grown in basal BHI 1906 i 142® 6,85 
Clostridium sp. strain 
A264 grown in basal + 
1% glucose 1557 + 124° 6.50 
^All cultures were grown overnight. The atmosphere was then 
changed from COg to 96/4 (CO2/O2), and incubated another 4 h with 
400 ug D 3 .  
^Values with the same letter are not statistically different 
(P < 0.05). 
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Table 6. Nonbiological production of lO-keto-Da by the autoxidation 
of cysteine 
a b Treatment Amount of lO-keto-D^ produced in 4 h 
(ng) 
Anaerobic water 138 ± 53'^ 
Cysteine'HCl solution 
(0.1% wt/vol) 1945 ± 251 
Cysteine'HCl solution 
(0.1% wt/vol) + super­
oxide dismutase (500 
units/ml) and catalase 
(1000 units/ml) 134 ± 24^ 
Cysteine'HCl solution 
(0.1% wt/vol) + heat-
inactivated superoxide 
dismutase (500 units/ml) 
and catalase (1000 
units/ml) 1200 ± 56 
^All treatments were anaerobically prepared and heat-sterilized 
prior to the addition of O2. 
^Values with the same letter are not statistically different 
(P < 0.05). 
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SECTION II. 
THE BIOLOGICAL ASSESSMENT OF VITAMIN D3 METABOLITES PRODUCED 
BY RUMEN BACTERIA 
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INTRODUCTION 
When incubated in the presence of rumen bacteria, cholecalciferol 
(vitamin D3) and 25-hydroxycholecalciferol (25-OH-D3) undergo oxidative 
metabolism to 5 (E)-19-nor-10-keto-vitamin D3 (lO-keto-Dg) and 5(E)-19-
nor—lO-keto—25—OH-D3 (10-keto—25-OH—D3), respectively (17). These 
metabolites were first isolated and characterized from vitro bacte­
rial incubations, and Sommerfeldt et al. (22) recently presented pre­
liminary evidence that 10-keto-[^Hj-Ds is present in the plasma of 
calves receiving oral [^H]-vitamin D3. However, the in vivo signifi­
cance of bacterial metabolism of vitamin D3 is not known. 
The rumen, its bacteria, and its physiological functions are simi­
lar to those found in the cecum and colon of nonruminant animals (1); 
thus, any significant rumen bacterial impact on vitamin D metabolism 
may have important ramifications in monogastric species such as humans. 
Supplementing foods (both livestock and human) with normal to excessive 
levels of vitamin D (10, 20) exposes gut bacteria to a significant pro­
portion of the vitamin D that animals receive. Thus, gut bacteria may 
influence the vitamin D status of the host. In addition to diet, the 
enterohepatic cycle represents the other major route for vitamin D to 
enter the intestine. Most of the major vitamin D sterols [vitamin D3, 
25-OH-D3, and 1,25-dihydroxyvitamin D3 (1,25-(0H)2D3] circulate in this 
cycle (3, 8). The relative contributions of diet and the enterohepatic 
cycle in providing vitamin D substrate for bacterial oxidation is not 
known. 
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The present study addresses the vivo significance, as measured 
by biological activity, entry into the circulation and pharmacokinetics 
of the recently described bacterial metabolites of vitamin D (17). We 
also briefly describe the production, purification, and initial charac­
terization of a new bacterial metabolite of vitamin D3, designated 
"Peak A." This compound is produced when vitamin D3 is incubated with 
Clostridium sp. strain A264, a rumen isolate known to affect the pro­
duction of lO-keto-Dg (7). 
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MATERIALS AND METHODS 
General 
High-pressure liquid chromatography (HPLC) was performed with a 
Waters Model LC-204 chromatograph fitted with a Model 6000-A pump and a 
Model 440 fixed-wavelength (254 and 313 nm) dual channel detector 
(Waters Associates, Milford, MA). HPLC columns (0.46 x 25 cm) were 
purchased from DuPont Instruments (Wilmington, DE), unless otherwise 
noted. Normal phase refers to microparticulate silica gel columns. 
Reverse phase refers to microparticulate silica gel columns derivatized 
with octa decylsilane (CDS). Spectral-grade solvents (Burdick and 
Jackson, Inc., Muskegon, MI) were used in all chromatography systems. 
Low resolution mass spectra were taken with a Finnigan Model 4021 qua­
druple mass spectrometer, using a solid probe. The U.V. spectra were 
obtained in ethanol with a Beckman Model 25 recording spectro­
photometer. 
Sterols 
Vitamin D3 was purchased from Sigma Chemical Co. (St. Louis, MO). 
[3a,^H]-Vitamin D3 was prepared as described by Barton et al. (4). 
Radiochemical purity of [^H]-vitamin D3 was confirmed by HPLC on a 
Zorbax Sil silicic acid column (0.46 x 25 cm) developed in hexane/iso-
propanol (99/1) at a flow rate of 2 ml/min. lO-Keto-Dg, used for stan­
dards, was a gift from Hoffmann-LaRoche, Inc. (Nutley, NJ). The 10-
keto-[^H]-D3, for internal standards, was prepared from [^H]-vitamin 
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Dg, as described by Napoli et al. (17). lO-Keto-25—OH-D3, for biologi­
cal assays, was also prepared as described by Napoli et al. (17). 
Isolation of lO-Keto-Dg From Bovine Plasma 
Two 150-kg Jersey steers were fed vitamin D3 (125 mg/day) for 30 
days. Twenty-four hours after administration of the last dose, the 
steers were euthanized with sodium pentobarbital in succinyl choline, 
and blood was collected in heparinized containers. All subsequent work 
was done under incandescent lights. Plasma was separated from whole 
cells by centrifugation. Eight hundred fifty ml of plasma were 
"spiked" with 100,000 dpm each of 5(E)- and 5(Z)-10-keto-[^H]-D3 (1.2 
Ci/mMol) and the plasma was then extracted (5). The extract was dried 
under reduced pressure and then was redissolved in ethanol and cooled 
in a dry ice/acetone bath. Insoluble lipids were removed by centrifu­
gation (2000 X g for 15 min) at -20°C. The supernatant was dried under 
reduced pressure to a volume of approximately 20 ml. This concentrated 
extract was mixed with 400 ml of acetonitrile and allowed to stand at 
room temperature for 30 min. Insoluble lipids were removed by centri­
fugation (2000 X g for 15 min) at 20°C. The supernatant which con­
tained lO-keto-Dg was dried and dissolved in 500 pi of hexane/isopro-
panol (9/1). The sample was applied in toto to a normal-phase HPLC 
prep column (Zorbax Sil, 2.2 x 25 cm), and the column was developed by 
using the same solvent at a flow rate of 5 ml/min. One-ml fractions 
were collected and the region containing radioactivity (30-40 ml) was 
collected for further purification, using successive normal-phase HPLC 
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analytical columns (Zorbax Sil, 0.45 x 25 cm) developed in hexane/iso-
propanol (99/1) at a flow rate of 2.5 ml/min, followed by hexane/iso-
propanol (97/3). The metabolite was recycled 2 times, for a total of 3 
passes through the final HPLC column. The fraction containing 10-
keto-Dg was then collected, dried under nitrogen, and redissolved in 
absolute ethanol for further characterization. 
Radioligand Binding Assays 
The comparison of relative binding affinities for lO-keto-Dg, 
10-keto-25-0H-D3, and "Peak A" to other vitamin D3 metabolites was ac­
complished with two sources of vitamin D-binding proteins: (1) the rat 
plasma vitamin D-binding protein diluted 1/5000 in 0.05 M potassium 
phosphate buffer containing 0.01% gelatin (11); (2) the specific 
l,25-(0H)2-vitamin D receptor isolated from bovine thymus, and assayed 
as described by Reinhardt et al. (19). 
Pharmacokinetics 
A plasma turnover rate for lO-keto-f^Hj-Dg was obtained in a 
150-kg castrated, male Jersey. Due to a limited supply of lO-keto-
[^Hj-Ds, only one animal could be used. The animal received 9.87 x 10^ 
dpm of 5(E)-10-keto-[^H]-D3 tracer. Blood samples (5 ml) were taken 
frequently beginning at 1 min for a period of 720 min. The radioactiv­
ity present as 10-keto-[^H]-D3 was assayed by adding 100 ng of radio-
inert lO-keto-Dg as an internal standard and extracting by the method 
of Bligh and Dyer (5). The extracts were chromatographed by using 
Sephadex LH-20 in hexane/chloroform/methanol (79/20/1) (17) and the 
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region corresponding to the elution of lO-keto-Ds was collected for 
HPLC. The samples were applied to a HPLC column and the column was 
developed in isopropanol/hexane (3/97). Recovery was estimated by us­
ing the internal standard peak heights. The data were analyzed by Dr. 
Charles Ramberg at the University of Pennsylvania by using CONSAM, a 
conversational version of the SAAM computer program (CONSAM User Guide, 
U. S. Department of Health and Human Services, Washington, DC). 
Biological Evaluation 
Weanling male rats were housed individually in overhanging plastic 
cages. They were fed vitamin D-deficient diets containing low calcium 
(0.005%) and normal phosphorus (0.3%) for 3 weeks prior to experimental 
use. At the end of 3 weeks, the rats were anesthetized with halothane 
and the test compounds given intrajugularly in 50 vl of a carrier solu­
tion containing ethanol/propylene glycol (3/7). Controls received the 
carrier solution alone. Twenty-four hours after injection, the rats 
were sacrificed by decapitation and their duodena were removed and used 
to measure intestinal calcium transport by the everted intestinal sac 
procedure (15). In addition, blood was collected from the animals in 
heparinized tubes; the blood was clarified by centrifugation (500 x g 
for 15 min at 25°C). Plasma calcium was measured by atomic absorption 
spectroscopy (24). The rats were on a diet essentially devoid of cal­
cium; therefore, serum calcium increases reflect mobilization of 
calcium from bone. 
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Preparation of Bacterial Culture Medium 
All manipulations were done anaerobically, as described by Hungate 
(12), except that cysteine'HCl was added to the media, and the media 
(20 ml) were dispensed into 100-ml serum bottles prior to steriliza­
tion. The basal medium consisted of Brain Heart Infusion (BHI) broth 
(BBL Microbiology Systems, Cockeysville, MD) supplemented with (wt/vol) 
0.05% cysteine'HCl, 0.1% resazurin, 0.3% arginine, and 0.04% Na2C03. 
All media was adjusted to pH 6.8, and anaerobically dispensed under 
Og-free COg. Cultures were transferred between serum bottles by using 
syringes which were pregassed with anaerobic COg. 
Isolation of Clostridium sp. Strain A264 
A mixed culture of rumen bacteria grown in BHI was heat-shocked at 
80°C for 15 min, and then transferred into fresh BHI broth. The re­
sulting suspension was streaked for isolation on BHI roll tubes (BHI 
broth + 2% agar). After incubation, colonies were picked and assayed 
for their ability to produce 10—keto—Dg. Active colonies were main­
tained on BHI slants (BHI broth + 1.5% agar); one strain, A264, was 
chosen for further study. 
Rumen Fluid 
Samples of rumen fluid were obtained from a fistulated Jersey cow 
(dry), fed a maintenance diet of alfalfa hay cubes and cracked corn 
(high roughage). The samples were taken 4 to 5 h after feeding. 
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strained through 4 layers of cheesecloth, and used within 30 min. Rumen 
fluid was used to determine if "Peak A" could be produced when mixed 
bacterial populations, similar to those found in vivo, were incubated 
with vitamin D3. 
Assay Conditions 
All clostridial cultures were grown overnight anaerobically in BHI 
broth before being assayed for the ability to metabolize vitamin D3. 
At the start of an experiment, the atmosphere was changed from CO2 to 
4% O2 in CO2. This was accomplished by inserting gas lines through the 
rubber stoppers. The reaction was then initiated by the addition of 
400 lig vitamin D3 and allowed to incubate 18 h at 39°C. Rumen fluid 
incubations were overlayed with 10% 0% in CO2 before the addition of 
either 400 yg of vitamin D3 or 2 yg of "Peak A." This concentration 
was previously shown to be optimal for lO-keto-Ds production by mixed 
cultures of rumen bacteria (7). Pure cultures of Clostridium sp. strain 
A264 required a low O2 concentration (4%); higher levels of O2 were 
inhibitory. The O2/CO2 mixture was obtained by using a dual flow meter 
(Matheson Co., Inc., East Rutherford, NJ). The concentration of O2 and 
CO2 were measured by using a Loenco Respiration and Blood Gas Analyzer 
(Altadena, CA). To insure that "Peak A" was derived from vitamin D3, 
overnight cultures of Clostridium sp. strain A264 were incubated with 
300 lig [^H]—vitamin D3 (1 pCi/300 yg) - These were analyzed as previ­
ously described. 
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Extraction and Chromatography 
A solid-phase extraction technique, using C^g Sep-Paks (Waters 
Associates) was developed. Following an incubation, 30 ml of aceto-
nitrile was added to 20 ml of a culture of Clostridium sp. strain A264 
or a strained rumen fluid culture. Then, 10,000 dpm of 10-keto-[^H]-D3 
were added to each 100-ml serum bottle as an internal standard (no 
labelled "Peak A" was available). This mixture was placed on a shaker 
(132 oscillations/min) for 20 min and then transferred to a 50-ml coni­
cal centrifuge tube. After centrifugation at 2000 x g for 10 min at 
25°C, the supernatant was decanted into a 100-ml serum bottle contain­
ing 20 ml of glass-distilled water. The entire 70 ml were passed 
through a C^g Sep-Pak, followed by 3 ml of methanol/water (70/30). 
Both lO-keto-Dg and "Peak A" were eluted with 8 ml of acetonitrile/water 
(90/10), collected and dried under nitrogen. The residue was dissolved 
in 500 ul of hexane/isopropanol (98/2), applied to a Waters Silica 
Sep-Pak and eluted with hexane/isopropanol (98/2). The first 8.5 ml of 
eluate contained the vitamin D3 fraction. The addition of 8 ml of 
hexane/isopropanol (90/10) was required to elute both 10-keto—D3 and 
"Peak A." This fraction was collected, dried under nitrogen and pre­
pared for reverse-phase HPLC by redissolving in 200 ul methanol/water 
(90/10). Reverse—phase HPLC was accomplished in methanol/water (90/10) 
at a flow rate of 2 ml/min. In this system, "Peak A" eluted between 
19-21 ml and 10—keto—D3 eluted between 31-33 ml. "Peak A" was col­
lected, dried under nitrogen, and stored in absolute ethanol at 0°C. 
The 10—keto—D3 peak was collected, dried and analyzed for radioactivitv 
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with a Beckman LS-9800 liquid scintillation counter. All reported val­
ues were corrected for quench and recovery of lO-keto-f^Hj-Dg. 
For mass spectral, or U.V. analysis, "Peak A" was subjected to 
more rigorous purification. After collecting "Peak A" from the re-
verse-phase system, it was dried under nitrogen and prepared for normal-
phase HPLC. The residue was dissolved in 97/3 hexane/isopropanol and 
chromatographed on a Whatman 10-ym Partisil column (4.6 x 25 cm). In 
this system, "Peak A" eluted between 19-21 ml. The final column was a 
Zorbax-NH2 column (4.6 x 25 cm) developed in 96/4 hexane/isopropanol; 
"Peak A" eluted between 31-33 ml. The fraction containing "Peak A" was 
collected and stored under nitrogen until further characterization 
could be performed. 
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RESULTS 
Isolation and Mass Spectral Detection of lO-Keto-Dg From Calves 
Approximately 600 ng of lO-keto-Dg were isolated from plasma lipid 
extracts of vitamin Da-intoxicated calves. The final HPLC column, 
which separated the 5(Z) and 5(E) stereoisomers of lO-keto-Dg, recon­
firmed the findings of Napoli et al. (17) that the 5(E) isomer is the 
natural isomeric form because no 5(Z) could be detected in plasma. The 
U.V. spectrum of the isolated compound displayed an absorbance maximum 
at 312 nm (Fig. 1) which is consistent with a 5(E), 7(Z), 10(19)-triene 
chromophore (17). Low resolution mass spectra (Fig. 2) attained for 
the putative plasma lO-keto-Dg was consistent with observed spectra for 
crystalline material (17). The spectrum had a molecular ion at m/z 386 
and a large peak at m/z 355 (m^-43). Loss of the side-chain was indi­
cated by a peak at m/z 273. Major peaks were also observed at m/z 179, 
177, 133, and 135, which are characteristic of lO-keto-Dg. 
Pharmacokinetics 
Figure 3 illustrates the rapid turnover rate observed for 
10-keto-[^H]-D3 in the bovine plasma. The half-life of 5(E)-10-
keto—D3 was approximately 6 min, indicating that this compound is 
rapidly removed or cleared from circulation and most probably the body. 
The mass turnover rate was estimated to be 18 ug/kg/day. 
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Biological Activity Evaluation 
The 5(E) (the biologically produced isomer) and 5(Z) (the isomer 
produced by U.V. irradiation) of 5(E)-10-keto derivatives of vitamin D3 
and "Peak A" were compared with vitamin D3 for biological activity. 
The intestinal calcium transport response of rats that received a sin­
gle dose of the test compound 24 h prior to sampling are shown in 
Tables 1 and 2. 5(Z)-10-Keto-D3 and 5(E)-10-keto-D3 were 40 and 80 
times less potent than vitamin D3, respectively, in stimulating intes­
tinal calcium transport (Table 1). The 5(Z) metabolite, but not the 
5(E) metabolite, displayed some bone-resorbing activity at the doses 
tested. "Peak A" stimulated calcium absorption from the gut (P < .05); 
however, it was approximately 20-fold less active than the vitamin D3 
(Table 2). "Peak A" did not mobilize detectable quantities of bone 
calcium at the doses tested. Co-dosing vitamin D3 and "Peak A" did not 
differ significantly from treatments with vitamin D3 alone, indicating 
that "Peak A" had no antagonistic effects on vitamin D3 activity. The 
10—keto derivatives of 25-OH-D3 (10-keto-25-0H-D3) neither stimulated 
calcium absorption from the gut nor mobilization of bone calcium at the 
doses tested (Table 3). The administration of 10-keto-25-0H-D3 daily 
over a 4-day period did not appear to enhance its biological activity 
(Table 4). It was not possible to test both the 5(E) and 5(Z) isomers 
of 10-keto-25-0H-D3 because of their limited supply, hence a racemic 
mixture was used in this study. 
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Relative Affinity for Plasma Vitamin D Binding Protein 
Table 5 illustrates the activities of the bacterial metabolites of 
vitamin D3 and 25-OH-D3 in the diluted rat plasma radioassay used to 
quantitate vitamin D and vitamin D metabolites (11). In addition, 
other vitamin D3 metabolites are included as reference points. About 
6000 times more 5(E)-IO—keto-Da than 25-OH—D3 was needed to displace 
50% of the 25-OH-the 5(Z) isomer required about 300 times more 
mass. The rat plasma binding protein did not appear to possess any 
affinity for "Peak A." Although both the 5(E) and 5(Z) isomers of 
10-keto-25-0H-D3 possessed greater displacement activity than any of 
the other bacterial metabolites tested, they were still 30-fold less 
active than 25-OH-D3. 
Relative Affinity for Thymus 1,25-(0H)2-Vitamin D3 Receptor Protein 
Table 6 illustrates the relative affinity of the bacterial metabo­
lites of vitamin D3 and 25-OH-D3 for the 1,25-receptor from thymus (19). 
Of these, only the 5(E) and 5(Z) isomers of 10-keto-25-0H-D3 displayed 
any significant ability to displace 1,25-(0H)2D3 from this protein. 
However, when compared to 1,25-(0H)2D3, both were approximately 140-fold 
less active. 
Characterization of "Peak A" 
Under incubation conditions which were optimal for lO-keto-Ds pro­
duction by mixed cultures of rumen bacteria (7), Clostridium sp. strain 
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A264 produced several new metabolites which had absorption maxima at 
254 nm (Fig. 4). The major product, designated "Peak A," was isolated 
and purified. When -vitamin D3 was used as the substrate, a major 
peak in radioactivity comigrated with "Peak A," indicating that this 
product originated from the parent [^H]-vitamin D3 (Fig. 5). Extensive 
metabolism to other compounds by Clostridium sp. strain A264 was noted 
by the authors (Fig. 4). 
In contrast to the results of Gardner et al. (7) for lO-keto-Dg, 
no "Peak A" could be detected in media without cells (Table 7). How­
ever, similar to results obtained with lO-keto-Dg production (7), "Peak 
A" production was also stimulated by the addition of small amounts of 
molecular Og. The catalytic factor(s) responsible for "Peak A" produc­
tion are somewhat heat-stable because "Peak A" was produced, at a re­
duced rate, following heat treatment (Table 7). Only trace amounts of 
"Peak A" could be detected in rumen fluid incubations with vitamin D3 
(data not shown). Interestingly, when 2 ug of "Peak A" was added to 
rumen fluid and incubated under identical conditions (10% O2 in CO2, at 
39°C for 18 h), only 10 to 25% could be recovered (data not shown). 
Thus, "Peak A" may be produced by rumen bacteria, but is not stable, 
and is probably metabolized further. 
The U.V. spectrum of purified "Peak A" revealed an E at 254 nm 
max 
and an at 220 nm (Fig. 6). This absorption maximum is close to 
that of vitamin D3 (264 nm) and may indicate that the triene double 
bond system is still intact in "Peak A." Preliminary mass spectral 
data indicated that the parent ion is at m/z 416, which represents an 
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increase of 32 mass units from the original vitamin D3 substrate. 
"Peak A" is located in between 25-OH-D3 and lO-keto-Dg in polarity on 
ODS or silica columns (Fig. 4). 
5(E)-lO-Keto-Da was isolated from the plasma of calves receiving 
large internal doses of vitamin D3. Structural confirmation was 
achieved by mass spectroscopy, comigration with synthetic standards and 
U.V. analysis. The presence of this compound, and not the 5(Z) isomer, 
in bovine plasma is consistent with the findings of Napoli et al. (17), 
who demonstrated that only the 5(E) isomer is produced by bacterial 
incubations in the absence of light. The source of this compound in 
plasma is of considerable interest in view of recent evidence that an 
analogous compound, 10-keto-25-0H-D3, is produced by kidney (13, 21) 
and phagocytic cells (6, 9). Two lines of evidence suggest that the 
oxidative cleavage at position 10 on the A—ring was achieved prior to 
entry into systemic circulation: (1) The compound 10-keto—25-OH-D3 was 
not present in the plasma of calves that received large oral doses of 
vitamin D3, albeit circulating concentrations of 25-OH-D3 were greater 
than 1000 ng/ml (normal range is 40-50 ng/ml). In view of this result, 
the C-10(19) oxidative pathway in the kidney, at least for 25-OH-D3, 
appears to be nonfunctional vivo and therefore not physiologically 
significant. (2) C-10(19) oxidation by rumen microbes has been demon­
strated vitro (17) . Since vitamin D3 was given orally, it was the 
only compound to be subjected to microbial metabolism. Hence, 10-
keto-D3, shown by us to be present in blood, is probably a direct re­
sult of bacterial metabolism of vitamin D in the rumen and absorption 
of this compound in the intestine. 
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When tested in vivo in rats, the natural 5(E) of lO-keto-Dg isomer 
was approximately 100-fold less potent than vitamin D3 at stimulating 
intestinal calcium absorption. This isomer did not cause bone calcium 
resorption at the doses tested. The nonnatural 5(Z) isomer, however, 
showed slightly greater calcium absorptive activity and minor bone 
resorptive activity. Both the 5(E) and 5(Z) isomers of 10-keto-
25-OH—D3 did not appear to have any significant effect on either the 
stimulation of calcium absorption from the gut or the mobilization of 
bone calcium. Interestingly, "Peak A" could stimulate calcium absorp­
tion (although 20-fold less than vitamin Dg), but could not affect bone 
calcium mobilization at the doses tested. The potential for such a 
metabolite in the treatment of osteoporosis and other bone diseases, in 
which normal calcium absorption from the gut is needed, should be ex­
plored further. 
Circulating, lO-keto-Dg is rapidly cleared. The plasma T^y^ was 
approximately 6 min. In addition, the metabolism of lO-keto-Dg to 
other metabolites vivo, especially to IS-nor-lO-OH-Dg or 19-nor-
10-keto-25-0H-D3, could not be detected (data not shown). The rapid 
plasma turnover can be partially explained by the poor binding of 
lO-keto-Ds to the plasma vitamin D binding protein (Table 5). Gen­
erally, compounds with higher affinity for this protein (e.g., 
25-OH-D3) have longer plasma half-lives than compounds with relatively 
low affinities [e.g., vitamin D3 and 1,25-(0H)2D3] (18). The produc­
tion of this compound, therefore, represents a terminal event - result­
ing in detoxification of large internal doses of vitamin Dy. 
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This hypothesis is also supported by the biological activity data. 
The naturally-occurring 5(E) isomer of lO-keto-Ds was biologically 
inert, in comparison to vitamin D3, at stimulating ^  vivo intestinal 
calcium absorption and bone calcium resorption. This also applies to 
10-keto-25-0H-D3 and "Peak A." The lack of iji vivo biologic activity 
can be partially explained by the lack of affinity for the 1,25-(0H)2D3 
receptor. Both the 5(E) and the 5(Z) isomers of lO-keto-Dg were ap­
proximately 5 X 10^ times less competitive than 1,25-(OH)203 for bind­
ing to the 1,25-(0H)2D3 receptor protein. "Peak A" had no measurable 
affinity and 10-keto-25-0H-D3 was approximately 150-fold less active 
than 1,25-(0H)2D3 in receptor-binding affinity. However, when tested 
45 in vitro for bone Ca resorptive activity in rat fetal long bone, the 
lO-keto—D3 metabolites were at least as active as 25-OH-D3 and markedly 
more active than vitamin D3 (23) . The vivo and vitro biological 
activities of vitamin D compounds have generally been highly correlated 
with affinities of the metabolites for the vitamin D receptor (18). 
Functionally, the metabolite—receptor complex is thought to interact 
with nuclear components, ultimately leading to transcriptional activa­
tion. The present observation of a dissociation between receptor-
binding and in vitro bone-resorptive activities may suggest that: (1) 
bone resorption is not totally a receptor-mediated event; (2) the bone 
has a different population of receptors compared to the intestine or 
thymus, with different affinities for vitamin D metabolites; or (3) the 
10—keto-Ds is being metabolized to a compound(s) that binds more avidly 
to the vitamin D receptor in the in vitro bone culture assays used. 
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No "Peak A" could be detected in the plasma of vitamin Dg-toxic 
calves, nor could it be detected after in vitro incubations in strained 
rumen fluid that produced lO-keto-Dg. It will be recalled that "Peak 
A" is a product obtained in a pure culture system and in an environment 
such as rumen fluid (a mixed bacterial population), it might not be 
stable and may be metabolized by other bacteria. Preliminary ^  vitro 
experiments with rumen fluid incubated with "Peak A" demonstrated that 
75 to 85% of the original starting material could not be recovered; and 
yet the chromatography system is highly efficient in recovery of both 
10-keto—Da and "Peak A" (approximately 76% recovery for "Peak A"). 
These results support the concept that "Peak A" would not be stable in 
vivo and, therefore, would be difficult to detect. 
In light of the anaerobic environment in the rumen, the participa­
tion of O2 in the production of both lO-keto-Dg and "Peak A" was a sur­
prising result; however, several investigators have noted a stimulatory 
effect of O2 on bile acid oxidation by anaerobic bacteria (2, 14, 16). 
As in our studies, the mechanism of oxidation and the concentration 
needed were ill-defined. Macdonald et al. (14) proposed a mechanism to 
explain the formation of 3-keto derivatives of bile, which involves 
intracellular ratios of NADP^/NADPH resulting from a higher Eh under O2 
atmospheres. Not enough is known about the C-10(19) oxidation of vita­
min D to extrapolate from the work of Macdonald et al. (14) at this 
time. 
In summary, the compound lO-keto-Dg was established as an in vivo 
metabolite of vitamin D3 in animals intoxicated with vitamin D3. These 
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observations are an extension of in vitro studies which demonstrated 
that lO-keto-Dg was a metabolite of vitamin D3 produced by rumen bacte­
ria. The low plasma values and rapid plasma turnover in conjunction 
with its lack of biological activity suggests that the C-10(19) oxida­
tion of vitamin D3 is a deactivation pathway which may play a role in 
allowing ruminants to tolerate relatively large oral doses of vitamin 
D. The quantitative importance of this newly described pathway is cur­
rently under investigation. 
In addition to any vivo role these metabolites may play, these 
transformation products and the responsible bacteria may have industri­
al importance in the production of new metabolites of vitamin D and 
other biologically active steroids. These reactions may provide desir­
able starting material or precursors for organic chemical syntheses, of 
new biologically-active metabolites. 
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Figure 1. U.V. spectrum of 19-nor-lO-keto-vitamin D3 isolated from 
plasma of vitamin D-toxic calves 
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Figure 2. Low-resolution electron impact mass spectrum of 19-nor-lO-
keto-vitamin D3 extracted from plasma of vitamin D-toxic 
calves 
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Figure 3. The disappearance of 10-keto-19-nor-[^H]-vitamin D3 from 
plasma 
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Figure 4. Bacterial metabolites of vitamin D3. (A) An elution profile 
of the lipid-soluble extract taken from an 18-h incubation 
of an overnight culture of Clostridium sp. strain A264 with 
400 pg vitamin D3 and a 4% 0% in CO2 atmosphere. This 
chromatograph was developed by reverse—phase HPLC in 
methanol/water (90/10). (B) Same as treatment "A," except 
no vitamin D3 was added. (C) The elution profile of two 
standards, 25-hydroxyvitamin D3 and 5(E)-19-nor-10-keto-
vitamin D3, developed on the same reverse-phase system 
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Figure 5. An elution profile of the lipid-soluble extract taken from 
an 18-h incubation of an overnight culture of Clostridium 
sp. strain A264 with 1 x 10® cpm of []-vitamin D3 and 
300 ug of vitamin Da. A 4% O2 in CO2 atmosphere was used 
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Figure 6. An ultraviolet spectrum of "Peak A" that was purified from 
in vitro incubations with Clostridium sp. strain A264. 
"Peak A" had an E of 254 nm and an E . of 220 nm 
max mxn 
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Table 1. Bone calcium mobilization and intestinal calcium transport in 
rats administered 19-nor—10-keto-vitamin D3 and vitamin D3 
Treatment 
^^Ca serosal/^^Ca 
mucosal 
Plasma 
calcium 
Control (17) 
% Control 
100 ± 3.5 100 ± 1.9 
Vitamin D3 
50 ng (14) 170 ±7.3 117 ±2.6 
5(Z)-19-Nor-10-keto-vitamin D3 
2000 ng (5) 
4000 ng (10) 
150 ± 15 
201 ± 12 
107 ±2.7* 
102 ± 2.2 
5(E)-19-Nor-10-keto-vitamin D3 
2000 ng (5) 
4000 ng (5) 
118 ±5.1 
161 ± 13.4 
101 ± 4.3 
99 ± 2.8 
Values significantly different from control (P < .05) are indi­
cated by the letter "A". 
The numbers in parentheses represent the number of rats/treatment 
group. 
108 
Table 2. Bone calcium mobilization and intestinal calcium transport in 
rats administered "Peak A" and vitamin D3 
Treatment 
^^Ca serosal/^^Ca 
mucosal 
Plasma 
calcium 
Control (5) 
% Control 
100 ± 14 100 ± 10 B,C 
Vitamin D3 
50 ng (6) 163 ± 23 119 ± 4 
"Peak A' 
100 ng (6) 120 23*' = 96 SC.D 
500 ng (6) 137 14® 99 gE.D 
1000 ng (5) 164 + 15^ 108 9® 
"Peak A" + vitamin D3 
500 ng + 50 ng (6) 175 ± 3r 125 ± 8 
Numbers in parentheses represent the number of rats/treatment 
group. 
^All values with the same letter are not statistically different 
(P < .05). 
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Table 3. Bone calcium mobilization and intestinal calcium transport in 
rats administered 19-nor—lO-keto-25-OH-vitamin D3 and 
25-OH-vitamin D3 
Treatment 
^^Ca serosal/^^Ca 
mucosal 
Plasma 
calcium 
Control (6) 100 ± 17 
% Control 
B 100 ± 9 B 
25-OH-vitamin D3 
25 ng (6) 179 ± 4f 114 ± 5^ 
19-Nor—10—keto-25-OH-vitamin Dg 
100 ng (6) 84 10® 100 9® 
250 ng (6) 95 23® 92 -r 7® 
500 ng (6) 97 20® 94 7® 
^Number in parentheses represent the number of rats/treatment 
group. 
All values with the same letter are not statistically different 
(P < .05). 
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Table 4. Bone calcium mobilization and intestinal calcium transport in 
rats administered 19-nor-10-keto-25-0H—vitamin D3 and 
25-OH-vitamin D3 daily^ 
Treatment 
^^Ca serosal/^^Ca 
mucosal 
Plasma 
calcium 
Control (6) 100 ± 20 
% Control 
B 100 ± 10 
25-OH-vitamin D3 
25 ng (6) 419 ± 83 133 ± 13' 
19—Nor-lO-keto-25-OH—vitamin D3 
100 ng (6) 141 ± 41 99 ± 7 B 
Rats were injected daily for 4 days. 
^The numbers in parentheses represent the number of observations/ 
treatment. 
All values with the same letter are not statistically different 
(P < .05). 
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Table 5. Ability of vitamin D3 metabolites to displace 25-OH-[^H]-
vitamin D3 from the 4.2 S rat plasma vitamin D binding 
protein 
Metabolite 
Amount that produces 50% 
displacement of 
25-OH-[^H]-vitamin D3 
(ng) 
Competitive index 
relative to 
25-OH-vitamin D3 
(%) 
25-OH-vitamin D3 0 .60  100.0 
5(Z)-19-nor-lO-keto-
25-OH-vitamin D3 20 .0  3.0 
5 (E)-19-nor-lO-keto-
25-OH-vitamin D3 20 .0  3.0 
1,25-(0H)2-vitamin D3 30.0 2 . 0  
Vitamin D3 32.0 1.9 
5(Z)-19-nor-lO-keto-
vitamin D3 200.0 0.3 
5(E)-19-nor-lO-keto-
vitamin D3 4000.0 0.015 
'Peak A" No activity 0.0 
^The amount of 25-OH-vitamin D3 that will displace 50% of the 
25-0H-[^H]-vitamin D3 divided by the amount of metabolite that will 
displace 50% of the 25-0H-[^H]-vitamin D3 times 100. 
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Table 6. Ability of vitamin D3 metabolites to displace 1,25-(OH)2-
r^ H]-vitamin D3 from the 3.75 S calf thymus receptor 
Metabolite 
Amount that produces 50% 
displacement of 1,25-
(QH)2[^H]-vitamin D3 
(ng) 
Competitive index 
relative to 1,25-
(OH)2-vitamin D3 
(%) 
1,25-(OH)2-vitamin D3 0.044 100.0 
5(Z)-19-not-10-keto-
25-OH-vitamin D3 6.31 0.69 
5(E)-19-nor-10-keto-
25-OH-vitamin D3 7.41 0.59 
25-OH-vitamin D3 
Vitamin D3 
7.59 
4600.0 
0.58 
0.00094 
5(Z)-19-nor-lO-keto-
vitamin D3 21200.0 0.00021 
5(E)-19-nor-10-keto-
vitamin D3 23500.0 0.00019 
"Peak A" No activity 0 . 0  
^The amount of 1,25-(OH)2-vitamin D3 that will displace 50% of the 
l,25-(0H)2-[^H]-vitamin D3 divided by the amount of metabolite that 
will displace 50% of the 1,25-(OH)2-[^H]-vitamin D3 times 100. 
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Table 7. A comparison of different preincubation treatments on 
"Peak A" production by Clostridium sp. strain A264 
Treatment Amount of "Peak A" produced 
(ng) 
Sterile, uninoculated BHI broth under 
4% OZ 
Not detected 
Overnight culture of Clostridium sp. 
strain A264 incubated under 4% O2 6307 ± 610' 
Overnight culture of Clostridium sp. 
strain A264 incubated under anaerobic 
conditions 1933 ± 212 B 
Overnight culture of Clostridium sp. 
strain A264 heat-killed and incu­
bated under 4% O2 883 ± 152' 
^All samples were incubated 18 h in the presence of vitamin D3. 
letter are not statistically different ^All values with the same 
(P < .05). 
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SUMMARY AND DISCUSSION 
Recently, it was discovered that in the presence of rumen bacteria 
vitamin D3 (a 9,10 seco-steroid) undergoes C-10(19) oxidation to 10— 
keto-Dg. This compound was the first documented bacterial metabolite 
of vitamin D (a eucaryotic vitamin), but relatively little was known 
about factors influencing its production or its biological signifi­
cance. Our in vitro studies in Section I clearly demonstrate that the 
C-10(19) oxidative pathway for vitamin D3 is unquestionably potentiated 
by bacteria. However, the discovery that lO-keto-Ds could also be pro­
duced by the autoxidation of cysteine or in heat-treated cultures 
tended to support a nonenzymatic mechanism. We propose that some an­
aerobic bacteria are capable of producing at least two heat-stable fac­
tors (one, <10,000 daltons; the other, >10,000 daltons) which catalyze 
theTproduction of oxygen radicals. These radicals, in turn, are di­
rectly responsible for the observed oxidation of vitamin D3. The in 
vitro requirement for molecular O2 by anaerobic bacteria tends to sup­
port this mechanism. If O2 is also an obligate iji vivo requirement, 
lO-keto-Dg production could occur at the epithelial wall of the gut 
where 0% is available. 
Our studies also resulted in the isolation of Clostridium sp. 
strain A264, a bacterium capable of generating lO-keto—D3. With this 
system, we were able to greatly optimize the production of these com­
pounds needed for biological assays. 
Section II demonstrated that lO-keto-Ds can be detected in the 
plasma of vitamin Ds-toxic calves. The short half-life observed for 
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lO-keto-Ds, coupled with its biological activity in vivo and ^  vitro, 
support that this oxidation is a deactivation pathway in vitamin D3 
metabolism. 
The metabolite "Peak A" is of particular interest because this 
compound could not be detected in the absence of cells or by the 
autoxidation of cysteine, thereby denoting a more direct relationship 
with bacteria. Interestingly, the 0% requirement demonstrated for 
lO-keto-Dg production also appeared for "Peak A." Although the role of 
O2 in lO-keto-Dg production can be explained by the presence of oxi­
dative radicals, its role in producing "Peak A" is not clear. 
The extent to which the bacterial flora interact with the vitamin 
D endocrine system under physiological levels of vitamin D is not 
known, but given the inert biological nature of these metabolites, they 
are probably significant only under conditions where the animal is 
challenged by toxic levels of vitamin D. In this situation, the bacte­
rial transformation of vitamin D3 to lO-keto-Ds and "Peak A" serve to 
deactivate vitamin Dg's biological activity, thus reducing the severity 
of the symptoms associated with toxicity. 
Future studies in this area should explore the metabolite "Peak 
A," which may have some use in the treatment of bone diseases marked by 
excessive calcium resorption. The potential interaction of bacteria 
with vitamin D in the enterohepatic cycle should also be examined in 
gnotobiotic animals and in animals on antibiotic regimes. In addition, 
the several new bacterial metabolites recently isolated should be char­
acterized and tested for biological activity. 
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